Podcasts about harvard th chan school

The Latest Research Behind Phantom Pain   You may have heard the saying, "Mind over Matter" a few times in your life. I know I have, but did you know that it is more than just a saying? Did you know that our brains are capable of helping us cope when we struggle, especially when we deal with pain? Today I learned how the brain can actually help us changing the way we think and perceive the pain we feel. We have the ability to redirect and reconnect our brain waves to cope with phantom pain, or any pain, that we experience. Today, I was honored to have on Dr Felipe Fregni, professor of Physical Medicine and Rehabilitation at Harvard Medical School and Professor of Epidemiology at Harvard TH Chan School of Public Health, as well as the Director of the laboratory of Neuromodulation at Spaulding Rehabilitation Hospital. He has been researching how the brain perceives pain and what is happening during bouts of pain to our brain. Dr Felipe Fregni, Harvard Professor   The hope is that if we learn how our brain works and how it changes during moments of pain or discomfort then we can start to use that information to better equip the individual to work through pain and eliminate it without medication! Wouldn't that be something! Studying the brain to find connections   Dr Fregni splits his time teaching at Harvard and working the lab at Spaulding Rehabilitation Hospital   Dr Fregni and his staff and students have been researching this topic for a while now and getting the data they need from participants, like myself, and they could use you too! Their goal is to create a device that you can wear to assist in pain elimination through brain waves. They started this study with bringing people into their lab to trial what they had created. Now they are onto phase 2 and getting new participants to work from home with their device. As an amputee I am excited to see research into phantom pain and how we deal with it and finding ways to cope without medication. Dr Fregni also mentioned that their research also branches into helping stroke victims and paralysis as well! When we figure out how pain is communicated within our body we can then begin to find ways to lessen or even eliminate it. One interesting thing we did touch on, which I stated at the very beginning was the mind over matter mentality. You may have heard me say that when I start hurting I tend to become active, I get moving and I find something to distract myself from thinking about the phantom pain. What Dr Fregni told me was that when we become active we start using our brain, we get neurons to fire and this makes for a healthy brain. So every time I'm struggling, my coping mechanism was to not think about the pain but to dive into something else. This is exactly what we should all be doing because we are creating connections in our brain, fire it up, and building it stronger. So mindset matters. Speaking to ourselves in positive ways matters. Even thinking about an activity we love to do creates connections in our brain for healing. What a powerful organ it is, indeed! I want to thank Dr Fregni for coming on and guiding us through how our brain is capable of helping us heal and for building this community of researchers to help those of us who are struggling with pain and need a better way to handle it. I look forward to seeing how your research builds a stronger and healthier tomorrow for us! Thank you! If you would like to take part in the clinical research happening right now, from the comfort of your own home you can reach out to Dr Fregni's department with the link below. I hope you all have a very blessed week. And as always until next time, Be Healthy, Be Happy, Be YOU!!! Much love,     To see if you qualify to participate in their study please click HERE

John McDonough of the Harvard TH Chan School of Public Health and Paul Hattis of the Lown Institute are joined by Tiffany Joseph, assistant professor of sociology and international affairs at Northeastern University, to discuss her new book, 'Not All In: Race, Immigration, and Healthcare Exclusion in the Age of Obamacare.'

Carbs are one of the most misunderstood aspects of nutrition. For decades, they've been praised, demonized, and debated. Today, low-carb diets are everywhere, but the reality is more nuanced. While over 80% of the carbs we eat come from low-quality, refined sources, the right kinds of carbs are essential for good health. In this episode, Professor Tim Spector breaks down the difference between good and bad carbs and explains why quality matters more than quantity. He explores how the rise of ultra-processed foods has led to an overconsumption of unhealthy carbohydrates, contributing to energy crashes, hunger, and long-term health issues. He also explains the benefits of fiber-rich carbs, their role in gut health, and why cutting carbs entirely may not be the best approach. The episode also answers common questions about carbs, including the best time to eat them, how to pair them for better digestion, and whether alternatives like almond flour are actually healthier. Tim also shares practical tips, such as why freezing bread might be a simple way to make it better for you.

About this episode: A new report on misinformation and disinformation from the National Academies of Science, Engineering, and Medicine is helping to define what misinformation is and how it starts and how to combat it. In this episode: a conversation about the findings, and how to get away from misinformation as a name-calling contest. Guest: Vish Viswanath is the Lee Kum Kee Professor of Health Communication at the Harvard TH Chan School of Public Health and chaired the blue ribbon panel examining misinformation about science. Host: Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, a faculty member in health policy, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: Science Misinformation, Its Origins and Impacts, and Mitigation Strategies Examined in New Report; Multisector Action Needed to Increase Visibility of, Access to High-Quality Science Information—National Academies of Science, Engineering, and Medicine The Anatomy of Deception: Conspiracy Theories, Distrust, and Public Health In America—Public Health On Call (October 2024) Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed

Justyce Jedlicka serves as the Food and Beverage Regulatory Liaison in North America for MilliporeSigma, where she is responsible for engaging with influencers in the food and beverage industry to align initiatives with regulatory compliance and promote best practices for food safety and quality testing methods. Justyce has been serving the food and beverage industry since 2013, and received both a B.S. degree in Chemistry and an M.B.A. degree from the University of Missouri in St. Louis. She currently serves as the Food Sciences Section Chair and Executive Board Member of the American Council of Independent Labs, and is a member of the International Association for Food Protection (IAFP), the International Society of Beverage Technologists (ISBT), and AOAC International. Sally Powell Price is MilliporeSigma's Regulatory and Public Health Expert for Food and Beverage Safety Testing in North America. Previously, she served as Director of Lab Operations at a biotech startup in Boston and was the Food Lab Supervisor at the New York City Department of Health Public Health Laboratory. She holds a B.S. degree in Biology from Hamilton College, an M.S. degree in Microbiology and Immunology from James Cook University in Australia, and did continuing coursework in public health and foodborne disease at Harvard TH Chan School of Public Health. She is a member of the Association of Food and Drug Officials (AFDO), the Association of Public Health Laboratories (APHL), the International Association for Food Protection (IAFP), and AOAC International. In this episode of Food Safety Matters, we speak with Justyce and Sally [2:41] about: Reasons why Escherichia coli and Shiga toxin-producing E. coli (STEC) are pathogens of particular concern for the food industry Existing food safety regulations to protect consumers from infections caused by E. coli MilliporeSigma solutions for STEC testing The future of STEC testing for food safety Resources that listeners can access to learn more about how the food supply is protected from E. coli contamination. Resources E. coli Detection for Food Safety Sponsored by: MilliporeSigma We Want to Hear from You! Please send us your questions and suggestions to podcast@food-safety.com

Alicia Yamin, Lecturer on Law and the Director of the Global Health and Rights Project at the Petrie-Flom Center for Health Law Policy, Biotechnology and Bioethics at Harvard Law School, talks about Mexico's judicial reform plan, which makes all federal judges elected, rather than appointed positions. Yamin, who is also Adjunct Senior Lecturer on Health Policy and Management at the Harvard TH Chan School of Public Health, considers this a threat to Mexican democracy.

Stefaan Verhulst and Andrew Schroeder speak with Brent Phillips, Humanitarian AI Today podcast producer, about Meta's Lama Impact Grants program supporting applications of artificial intelligence for social good and a recent workshop that Meta organized for their 2024 Lama Impact Grant finalists. Stefaan, Andrew and Brent also discuss collective intelligence, large language models, data accessibility and making data AI ready, data collection and standardization initiatives geared for humanitarian actors, the impact of AI on humanitarian operations, localization, and how humanitarian actors can collaborate around advancing humanitarian AI. Dr. Stefaan G. Verhulst is an expert in using data and technology for social impact. He is the Co-Founder of several research organizations including the Governance Laboratory (GovLab) at New York University and The DataTank base in Brussels. He focuses on using advances in science and technology, including data and artificial intelligence,  to improve decision-making and problem-solving. He is also the Editor-in-Chief of the open-access journal Data & Policy and has served as a member of several expert groups on data and technology, including the High-Level Expert Group to the European Commission on Business-to-Government Data Sharing and the Expert Group to Eurostat on using Private Sector data for Official Statistics. Dr. Verhulst has been recognized as one of the 10 Most Influential Academics in Digital Government globally. He has published extensively on these topics, including several books, and has been invited to speak at international conferences, including TED and the UN World Data Forum. He is asked regularly to provide counsel on data stewardship to a variety of public and private organizations. Dr. Andrew Schroeder is the Vice President of Research and Analysis for Direct Relief. He leads Direct Relief's work in data science, GIS, and humanitarian innovation. He has worked in a consulting and advisory capacity for the World Bank, United Nations Development Program (UNDP) and World Food Programme (WFP), as well as being a member of the health data experts committee for Meta (formerly Facebook). Dr. Schroeder is the co-founder, along with colleagues at Harvard TH Chan School of Public Health and Harvard Medical School, of CrisisReady, a research and response platform for translating private data into public good for disasters and health emergencies. He is also the co-founder and former Board President of the global nonprofit WeRobotics.org, which builds local capacity in robotics applications for humanitarian aid, development, and global health in nearly 40 countries around the world. Andrew earned his Ph.D. in Social and Cultural Analysis from New York University and his Masters of Public Policy (MPP) and certification in Science, Technology and Public Policy (STPP) from the Gerald R. Ford School of Public Policy at the University of Michigan.

If you're enjoying this interview click this link to join Dr. Ramsey's weekly newsletter and to download free resources: https://drewramseymd.com/free-resources/ The medical profession is undergoing a transformative shift as it intersects with the rapid advancements in artificial intelligence, digital technologies, and social media. In this episode, we explore how these emerging domains are shaping the future of healthcare and impacting the mental health and well-being of medical practitioners. We speak to Dr. Austin Chiang, Chief Medical Officer for the Endoscopy business of Medtronic, about his experience working in the medical field. He shares openly about the importance of mental health, creativity, and sharing knowledge on social media.  Being a Gastroenterologist, he also provides practical advice for optimizing your gut health and supercharging your nutrition.  ==== 0:00 Intro 2:24 Shedding Light on Gut Health 4:18 Being a Endoscopist 6:50 When to See a Gastroenterologist  11:16 Fundamental Ways to Help the Gut 13:35 Fiber Foods & Supplements 18:52 AI & Gastroenterology 27:53 Taking Care of Mental Health on the Road 31:26 Working on Innovation with Medtronic 33:56 Creativity in Medicine 36:13 How Social Media is Changing Medicine 40:09 Mental Health Tips for Making it Through Med School 44:45 Healthy Boundaries with Social Media 50:06 Sharing Vulnerably  53:33 Giving People the Tools to Share on Social Media 56:50 Conclusion ==== Dr. Chiang is the first Chief Medical Officer for the Endoscopy business of Medtronic, the global leader in health technology. He is also currently an Assistant Professor of Medicine at an academic teaching hospital in Philadelphia, PA, and serves as the Director of the Endoscopic Weight Loss Program. He completed his undergraduate studies at Duke University before earning his MD at Columbia University. He stayed for Internal Medicine residency at New York Presbyterian Hospital and completed his GI and bariatric endoscopy fellowships at Brigham and Women's Hospital. He obtained his MPH from the Harvard TH Chan School of Public Health before completing an advanced endoscopy fellowship at Jefferson.  Passionate about empowering patients with accurate medical information online, he is one of the most influential voices in the field of gastroenterology across multiple social media platforms including Instagram, X/Twitter, TikTok, and YouTube with over 700,000 followers and over 180 million views. Dr. Chiang has conducted extensive research in social media and is champion of physician presence on social media and was formerly the Chief Medical Social Media Officer of Jefferson Health and Founding President of the Association for Healthcare Social Media (AHSM, @ahsm_org), the first 501(c)(3) professional society for health professional social media use. He has worked closely with all major national GI societies on social media efforts and was 2018's Healio Gastroenterology Disruptive Innovator of the Year, The Philadelphia Inquirer's 2019 Influencers of Healthcare Rookie of the Year, and among 2019 Medscape Top 20 Social Media Physicians, and a 2021 GLAAD Media Award Nominee. He spoke at South by Southwest (SXSW) 2021, and his role in social media has been featured by The New York Times, CNBC, and BBC News. He sits on the inaugural YouTube Health Advisory Board and in 2022, joined the White House Healthcare Leaders in Social Media Roundtable.  In April 2024 he will be releasing Gut: An Owner's Guide (DK/Penguin Random House) an illustrated, colorful book to help educate the general public about their gut health, gastroenterological procedures, and innovation. Website: https://www.austinchiang.com/ Book: https://www.austinchiang.com/gut-book ==== Connect with Dr. Drew Ramsey: Instagram: https://www.instagram.com/drewramseymd/ Website: https://drewramseymd.com

In today's episode, with Dr. Abrania Marrero, we'll discuss the loss of food culture and reclaiming agriculture in marginalized communities, as well as interdisciplinary approaches to getting there. Dr. Abrania Marrero is a postdoctoral research fellow in the Department of Nutrition at Harvard TH Chan School of Public Health. With a focus on food systems in small island states, including her native Puerto Rico, her research portfolio interrogates the interdependence of human and planetary health; the cultural and geopolitical landscapes on which they arise; and agentic pathways toward more just, nutritious, and climate-resilient futures. On this Episode you will Learn:  How Dr, Abrania takes a multidisciplinary approach to her work, particularly in small island ecosystems The impacts of colonial and climatic shocks on local agriculture in Puerto Rico and how those shocks have affected traditional food systems Promotion of climate resilient farming practices and the challenges and solutions that surround it Connect with Yumlish! Website Instagram Twitter Facebook LinkedIn YouTube  Connect with Dr. Abrania Marrero! Website  Twitter LinkedIn Resources --- Send in a voice message: https://podcasters.spotify.com/pod/show/yumlish/message

As a nutrition and planetary health researcher, Christopher Golden takes a keen interest in the second of 17 United Nations Sustainable Development Goals and its aim to end hunger.But Golden's research also focuses on “hidden hunger,” a term he uses to describe the impact of dietary deficiencies in micronutrients such as iron, zinc, fatty acids, and vitamins A and B12.Hidden hunger, he argues in the second episode of the How to Save Humanity in 17 Goals podcast series, could be better addressed if more people adopted a diet that includes more ‘blue' or aquatic foods. These include fish, molluscs and plant species.Golden, who is based at Harvard TH Chan School of Public Health in Boston, Massachusetts, says discussions about hunger and food security have tended to focus on terrestrial food production.As soil nutrient levels deplete and farmland becomes scarcer as human populations rise, more attention needs to be paid to marine and freshwater food sources, he adds.But rising sea temperatures threaten millions of people in equatorial regions whose diets are rich in blue foods. As aquatic species migrate polewards in search of cooler waters, their livelihoods and food security are at risk.Each episode of How to Save Humanity in 17 Goals, a Working Scientist podcast series from Nature Careers, features researchers whose work addresses one or more the targets. The first six episodes are produced in partnership with Nature Food, and introduced by Juliana Gil, its chief editor. Hosted on Acast. See acast.com/privacy for more information.

Michaela Kerrissey, PhD, MS, is an assistant professor of management on the faculty at the Harvard TH Chan School of Public Health. She identifies how healthcare organizations innovate, improve, and integrate services, specifically how teams solve problems that cross organizational boundaries. Her research has been published in leading academic journals in both management and healthcare, such as Administrative Science Quarterly and Health Affairs. She has received Best Paper awards from the Academy of Management and the Interdisciplinary Network for Group Research and was listed in 2023 on Thinkers50 Radar, a global ranking of top management thinkers.Dr. Kerrissey designed the Management Science for a New Era course at the School of Public Health. She also teaches in multiple executive programs at Harvard's business and medical schools and received the Bok Center award for excellence in teaching.Dr. Kerrissey holds a BA from Duke University, an MS from the Harvard School of Public Health, and a PhD from Harvard University. She was awarded the Robertson Scholarship at Duke, a Hart Leaders Fellowship, and a Reynolds Fellowship at Harvard. Prior to her academic engagement, she was a consulting team leader at The Bridgespan Group, which was launched by Bain & Company.Link to claim CME credit: https://www.surveymonkey.com/r/3DXCFW3CME credit is available for up to 3 years after the stated release dateContact CEOD@bmhcc.org if you have any questions about claiming credit.

The daily disposal of plastic waste, including items like coffee cup lids, wrappers, and containers, poses a significant environmental threat. In 2021, global trash generation reached 400 million tons, with the U.S. contributing 51 million tons, only recycling 2.4 million tons. Plastics, derived from fossil fuels, undergo an energy-intensive process emitting greenhouse gases. Plastic pollution harms wildlife, habitats, and human populations, with synthetic plastics constituting 95% of all plastics ever made.  Plastics, introduced commercially in the 1950s, offer convenience but have a low recovery rate compared to materials like glass and paper. Inefficiencies in recycling, attributed to processing challenges, hinder their reuse. Plastic's exponential production since the 1950s, driven by qualities like ease of shaping and low cost, comes at a significant cost to health and the environment.  Plastic's impact on sea life is well-documented, but increasing studies focus on its effects on human health, fertility, land ecosystems, crops, and plants. Plastic's main ingredients originate from oil and natural gas, with additives containing hazardous substances. Plastic packaging, with over 4,000 chemicals, poses risks to human health, demanding a reconsideration of reliance on this pervasive material and a commitment to sustainable alternatives.  Join Host Bernice Butler with Mary Johnson from Harvard TH Chan School of Public Health and Nena Shaw with the EPA to explore and unpack this phenomenon. --- Support this podcast: https://podcasters.spotify.com/pod/show/healthy-radio/support

Welcome to the premier of Season 4 of the Keri Report! To kick off this season, I dive deep into a topic that concerns a lot of us - especially me! - by looking at the latest news on alcohol that has caused quite a ruckus in the nutrition community.   In this episode, I'm joined by Dr Eric Rimm, a Professor of Epidemiology and Nutrition and Director of the Program in cardiovascular epidemiology in the Harvard TH Chan School of Public Health, and Professor of Medicine at the Harvard Medical School. He's internationally recognized for his extensive work in the study of the health effects of light to moderate alcohol consumption. We go over the latest studies, what exactly moderate drinking is by the numbers, and whether the research on drinking actually has changed at all. Stay tuned!   ---   The Keri Report dissects health and nutrition with a no-nonsense approach.   Nutritionist, yoga teacher, and author of The Small Change Diet Keri Gans delivers her straightforward and sometimes controversial approach to what's current in the health and nutrition world. Her fun and engaging personality will leave you with a wealth of information on need-to-know hot topics for your overall well-being.   To find more information and to join Keri's mailing list, visit her website: https://kerigansny.com/   Instagram/Twitter: @kerigans Facebook Page: @KeriGansNY This episode was produced by Jess Schmidt. Visit her website at https://www.jessdoespodcasting.com

Sally Powell Price is MilliporeSigma's Regulatory and Public Health Expert for Food and Beverage Safety Testing in North America. Previously, she served as Director of Lab Operations at a biotech startup in Boston and was the Food Lab Supervisor at the New York City Department of Health Public Health Laboratory. She holds a B.S. in Biology from Hamilton College, a M.S. in Microbiology and Immunology from James Cook University in Australia, and did continuing coursework in public health and foodborne disease at Harvard TH Chan School of Public Health. She is a member of the Association of Food and Drug Officials (AFDO), the Association of Public Health Laboratories (APHL), the International Association for Food Protection (IAFP) and AOAC International.  Justyce Jedlicka serves as the Food and Beverage Regulatory Liaison in North America for MilliporeSigma. Responsible for engaging with influencers in the food and beverage industry to align initiatives with regulatory compliance and promote best practices for food safety and quality testing methods, Justyce has been serving the food and beverage industry since 2013. She received a B.S. in Chemistry and an M.B.A. from the University of Missouri in St. Louis. She currently serves as the Food Sciences Section Chair and Executive Board Member of the American Council of Independent Labs and is a member of IAFP, International Society of Beverage Technologists (ISBT), and AOAC International. In this episode of Food Safety Matters, we speak with Sally and Justyce [3:00] about The impact of food safety failures in baby formula production in recent years The risk factors for contamination in infant and baby foods and why contamination has been more of an issue at late The regulatory changes being made in response to recent foodborne illness outbreaks linked to formula How protecting infant health influences sustainability and corporate responsibility initiatives How customers can leverage companies like MilliporeSigma to take the right steps towards safety and compliance Recommended resources and trade organizations for those interested in understanding the issue of infant formula safety in greater depth. Resources: "Ask the Expert: How to Choose the Right Method for Microbial Testing in Infant Formula?" Support for Food and Beverage Testing Heroes  Sponsored by:MilliporeSigma We Want to Hear from You!Please send us your questions and suggestions to podcast@food-safety.com

Clinging to research findings at the expense of understanding another's perspective may hinder progress in the world of policy. Dr. Jeff Glenns shares with us best practices for health policymaking, emphasizing the importance of listening to others and understanding the political climate surrounding public health.  As avid Survivor fans, Glenn and Dr. Cougar Hall also reflect on life lessons they've learned from the reality tv show. Bio Dr. Jeff Glenn is a BYU professor best known by undergraduate students for his teachings on policy. Glenn completed his Doctor of Public Health (DrPH) at the Harvard TH Chan School of Public Health where he studied health policy and systems change. Prior to his doctoral education, Glenn worked as a Presidential Management Fellow and Public Health Advisor at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA where he helped establish the agency's global cancer program. He holds a Master of Public Administration (MPA) from the University of Southern California and a BA in International Relations from Brigham Young University. Glenn grew up in Salt Lake City, UT and enjoys spending time outdoors and traveling to new places with his wife, Kathryn, and their three children. Recorded, Edited & Produced by Paige Sherwood, Isabella Loosle, and Tanya Gale

How can statistics aid research about health effects of air pollution and climate change? What is the underlying difference between data science and statistics? What is the Harvard data science initiative? Francesca Dominici is here to answer all these questions for you! Dr. Dominici obtained her PhD degree in statistics from University of Padua in Italy and currently is Clarence James Gamble Professor of Biostatistics, Population and Data Science at the Harvard TH Chan School of Public Health and Co-Director of the Harvard Data Science Initiative. The main focus of her research is to utilize statistical techniques in addressing significant problems in environmental health science, pollution and climate change. Her studies have resulted in a direct and continuous impact on air quality policies, leading to more stringent standards for ambient air quality in the United States. In addition, she has a keen interest in Bayesian causal inference methods for large-scale observational data and their potential application to comparative effectiveness research in cancer. Other than the academic achievements, Dr. Dominici also devotes herself into promoting diversity in academia. Let's dive into this episode to see what she shared with us! Please visit our website https://biostatisticspodcast.github.io/ for the latest updates and transcripts of the published episodes. If you have any comments, feedback or suggestions, feel free to email us via biostatisticspodcast@gmail.com or DM us on Twitter @BiostatsPodcast Powered by Firstory Hosting

In this episode, Dr Jamie Coleman is joined by Elzerie de Jager, MBBS(Hons), PhD, from the University of Vermont and the Center for Surgery and Public Health, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School and Harvard TH Chan School of Public Health; and LD Britt MD, MPH, FACS, from the Department of Surgery, Eastern Virginia Medical School. They discuss their study, in which a Delphi panel identified 125 potential disparity-sensitive measures which could be used to track health disparity, evaluate the impact of focused interventions, and reduce healthcare inequity. Learn more about the Journal of the American College of Surgeons, a monthly peer-reviewed journal publishing original contributions on all aspects of surgery, including scientific articles, collective reviews, experimental investigations, and more. #JACSOperativeWord

In this episode we have two interviews about two different—but both very important—topics. In the second interview, Dr. Celestin Hategeka, from the Department of Global Health and Population, Harvard TH Chan School of Public Health, discusses his recently published systematic review in PLoS Medicine that identified several unmet needs in noncommunicable disease prevention, as well as control interventions, in low- and middle-income countries. But first, our regular contributor, Dr. MedLaw—a board-certified radiologist and medical malpractice attorney—discusses the important topic of employment contracts. As always, Dr. MedLaw serves us a fascinating twist with her insights! Enjoy listening!Additional reading:Hategeka C, Adu P, Desloge A, Marten R, Shao R, Tian M, Wei T, Kruk ME. Implementation research on noncommunicable disease prevention and control interventions in low- and middle-income countries: A systematic review. PLoS Med. 2022 Jul 25;19(7):e1004055.

In today's episode, we chat with Alejandra Salemi, MPH, MTS, who is currently a Doctoral Student in Population Health Sciences at Duke University. Alejandra is interested in understanding the intersection of religion, community health and wellbeing. She is someone with experience using her coaching skillsets to help people around their health and wellness. She got her Bachelors in Public Health at University of Florida. She then got her Master of Public Health at University of Florida followed by her Master of Theological Studies at Harvard University. And is currently working towards a doctoral degree at Duke University.Shownotes: https://thephmillennial.com/episode119Join Community Health & Wellness Discord: https://www.thephmillennial.com/joinAlejandra Salemi, MPH, MTS on LinkedIn: https://www.linkedin.com/in/alejandrasalemi0315/Omari on IG: https://www.instagram.com/thephmillennial Omari on LinkedIn: https://www.linkedin.com/in/omari-richins All ways to support The Public Health Millennial: https://thephmillennial.com/support/ Shop at The Public Health Store: https://thephmillennial.com/shop/Chapters:0:00 - Teaser clip0:39 - Public Health careers podcast intro1:10 - Episode intro3:02 - How are you doing?4:00 - Personal Background5:35 - What does Public Health mean to you?5:36 - Shop ad6:15 - Back to episode7:54 - Journey in Public Health11:24 - How did you know you wanted to do Public Health13:19 - How did you choose your concentration?14:55 - Position as Cognito Program Ambassador @ UF Counseling and Wellness Center19:58 - Takeaways from time in schooling22:34 - Masters in Theological studies @ Harvard28:45 - Concentration at Harvard31:03 - Team Lead role at Harvard34:34 - What made you switch masters programs?36:12 - Position as Research assistant at FXB centre at Harvard41:03 - Position as Research assistant at Harvard TH Chan School of Public Health45:00 - Do you think you git what you wanted from your Masters degree46:50 - Current time as PhD student at Duke51:05 - Discord ad51:52 - Back to episode54:56 - How can someone start their own platform58:47 - Where so you see yourself in the future?1:00:45 - Advice for students pursuing public health1:01:41 - Advice for someone wanting to be where you are1:03:18 - What is something you're working on improving right now?1:04:10 - Professional recommendations1:05:15 - Where can people connect with you?Support the show

Listen to a blog summary about a trending research paper published by Aging (Aging-US as the cover of Volume 14, Issue 17, entitled, "Extracellular microRNA and cognitive function in a prospective cohort of older men: The Veterans Affairs Normative Aging Study.” __________________________________________ Can factors in our bloodstream tell us about our cognitive abilities or predict cognitive decline later in life? Among individuals with dementias, including Alzheimer's disease (AD), studies have identified extracellular microRNAs (miRNAs) as potential biomarkers of cognitive impairment. In cognitively normal individuals, however, this association has not yet been fully investigated. “Understanding the functions of miRNAs in the earliest stages of cognitive decline will expand our knowledge on the biology of prodromal AD and the roles of circulating miRNAs in neurodegenerative diseases and could result in identification of therapeutic targets to guide drug development [17].” In a new research paper, published on the cover of Volume 14, Issue 17, of Aging (listed as “Aging (Albany NY)” by Medline/PubMed and “Aging-US” by Web of Science), researchers Nicole Comfort, Haotian Wu, Peter De Hoff, Aishwarya Vuppala, Pantel S. Vokonas, Avron Spiro, Marc Weisskopf, Brent A. Coull, Louise C. Laurent, Andrea A. Baccarelli, and Joel Schwartz from Columbia University Mailman School of Public Health, University of California San Diego, VA Boston Healthcare System, Boston University School of Medicine, and Harvard TH Chan School of Public Health investigated expression levels of extracellular miRNAs circulating in blood plasma taken from cognitively normal men and the association between these miRNAs and cognitive function. Their secondary goal was to investigate the genes and biological pathways associated with miRNAs linked to cognitive function or decline. The research paper was published on September 6, 2022, and entitled, “Extracellular microRNA and cognitive function in a prospective cohort of older men: The Veterans Affairs Normative Aging Study.” Full blog - https://aging-us.org/2022/09/can-micrornas-in-the-bloodstream-signal-cognitive-decline/ DOI - https://doi.org/10.18632/aging.204268 Corresponding author - Nicole Comfort - nicole.comfort@columbia.edu Sign up for free Altmetric alerts about this article - https://aging.altmetric.com/details/email_updates?id=10.18632%2Faging.204268 Press release - https://aging-us.com/news_room/Extracellular-microRNA-and-cognitive-function-in-a-prospective-cohort-of-older-men Keywords - aging, plasma, extracellular RNA, RNA-seq, microRNA, cognitive decline, cognitive impairment About Aging-US Launched in 2009, Aging-US publishes papers of general interest and biological significance in all fields of aging research and age-related diseases, including cancer—and now, with a special focus on COVID-19 vulnerability as an age-dependent syndrome. Topics in Aging-US go beyond traditional gerontology, including, but not limited to, cellular and molecular biology, human age-related diseases, pathology in model organisms, signal transduction pathways (e.g., p53, sirtuins, and PI-3K/AKT/mTOR, among others), and approaches to modulating these signaling pathways. Please visit our website at https://www.Aging-US.com​​ and connect with us: SoundCloud - https://soundcloud.com/Aging-Us Facebook - https://www.facebook.com/AgingUS/ Twitter - https://twitter.com/AgingJrnl Instagram - https://www.instagram.com/agingjrnl/ YouTube - https://www.youtube.com/agingus​ LinkedIn - https://www.linkedin.com/company/aging/ Pinterest - https://www.pinterest.com/AgingUS/ Media Contact 18009220957 MEDIA@IMPACTJOURNALS.COM

A new research paper was published on the cover of Aging (Aging-US) Volume 14, Issue 17, entitled, “Extracellular microRNA and cognitive function in a prospective cohort of older men: The Veterans Affairs Normative Aging Study.” Aging-related cognitive decline is an early symptom of Alzheimer's disease and other dementias, and on its own can have substantial consequences on an individual's ability to perform important everyday functions. Despite increasing interest in the potential roles of extracellular microRNAs (miRNAs) in central nervous system (CNS) pathologies, there has been little research on extracellular miRNAs in early stages of cognitive decline. In a new study, researchers Nicole Comfort, Haotian Wu, Peter De Hoff, Aishwarya Vuppala, Pantel S. Vokonas, Avron Spiro, Marc Weisskopf, Brent A. Coull, Louise C. Laurent, Andrea A. Baccarelli, and Joel Schwartz from Columbia University Mailman School of Public Health, University of California San Diego, VA Boston Healthcare System, Boston University School of Medicine, and Harvard TH Chan School of Public Health leveraged the longitudinal Normative Aging Study (NAS) cohort to investigate associations between plasma miRNAs and cognitive function among cognitively normal men. “In a cohort of older men from Massachusetts, we investigated associations between plasma miRNAs and global cognition and rate of global cognitive decline measured by the MMSE.” Full press release - https://aging-us.net/2022/09/15/aging-extracellular-microrna-and-cognitive-function-in-a-prospective-cohort-of-older-men-the-veterans-affairs-normative-aging-study/ DOI: https://doi.org/10.18632/aging.204268 Corresponding Author: Nicole Comfort – nicole.comfort@columbia.edu Keywords: plasma, extracellular RNA, RNA-seq, microRNA, cognitive decline, cognitive impairment Sign up for free Altmetric alerts about this article: https://aging.altmetric.com/details/email_updates?id=10.18632%2Faging.204268 About Aging-US: Launched in 2009, Aging (Aging-US) publishes papers of general interest and biological significance in all fields of aging research and age-related diseases, including cancer—and now, with a special focus on COVID-19 vulnerability as an age-dependent syndrome. Topics in Aging go beyond traditional gerontology, including, but not limited to, cellular and molecular biology, human age-related diseases, pathology in model organisms, signal transduction pathways (e.g., p53, sirtuins, and PI-3K/AKT/mTOR, among others), and approaches to modulating these signaling pathways. Please visit our website at www.Aging-US.com​​ and connect with us: SoundCloud – https://soundcloud.com/Aging-Us Facebook – https://www.facebook.com/AgingUS/ Twitter – https://twitter.com/AgingJrnl Instagram – https://www.instagram.com/agingjrnl/ YouTube – https://www.youtube.com/agingus​ LinkedIn – https://www.linkedin.com/company/aging/ Reddit – https://www.reddit.com/user/AgingUS Pinterest – https://www.pinterest.com/AgingUS/ For media inquiries, contact media@impactjournals.com.

On this episode of Gist Healthcare Daily, the Senate passes a bill with major reforms for seniors on Medicare. A new NPR, the Robert Wood Johnson Foundation, and Harvard TH Chan School of Public Health poll finds a fifth of sick patients weren't able to get necessary medical care. And there are rumors that CVS is interested in acquiring Signify Health. See acast.com/privacy for privacy and opt-out information.

Interoperability. Let's just review a few key points that probably everybody listening knows but certainly bear repeating because they matter. I don't want to dig into the technical or regulatory details of interoperability. That is above my pay grade. But I want to talk about the really important stuff that maybe doesn't get talked about a whole lot because you say the word interoperability and it's like the magic word that transports the unwary into the land of shadow and smoke and mist. It's like a self-published YA (young adult) novel half the time. But let's start here: First of all, consider that a lot of healthcare these days is conceived of as a scattering of micro-moments. It's not even like we think of patients one at a time. We think about patients one ICD-10 code at a time. And we think about those ICD-10 codes in 20-minute increments whenever a patient happens to show up in clinic. The average Medicare patient these days sees five specialists and more than one PCP a lot of times. So, we're not only breaking that patient down into codes per minute or something, but this is further broken down by clinician or practice. Now consider that everybody knows—and when I say everybody knows, I mean it's inarguable at this point—health happens at the whole-patient level, at the whole-person level, more accurately. It happens at the community level: 80% of patient outcomes are going to derive from what that patient does when they leave the office and whether they are able to and health literate enough to construct a reconciled treatment plan for themselves from the bits and pieces of information they've received scattered all over the place. You know in Star Trek when someone gets into the transporter to beam down to a planet and their whole body splinters into a gazillion little pieces? That's how our healthcare industry treats patients. They are frozen in that moment and rarely, if ever, become whole on the other side. So, when we talk about interoperability, what we're really talking about is a means to an end. What we are discussing is creating the ability to treat the whole patient or—Heaven forbid!—consider the whole community because we have enough data that we can accurately and adequately see the whole picture. We are able to avoid prescribing a treatment that is dangerous to the patient, inefficient, duplicative, or low quality—which is what happens over and over again. It's no amazing surprise that our healthcare industry wastes $1 in $4 we spend and doesn't net outcomes that are great in almost any respect when compared to other countries. Let me say this more bluntly, as if that wasn't already pretty blunt: If I don't know relevant and important details about my patient, then I cannot consistently deliver care that is high quality, safe, or cost conscious due to service duplication or uncoordinated care. I mean, how is anybody supposed to deliver evidence-based care when a lot of evidence may or may not be missing? So basically, without interoperability piping in the right patient information, I cannot succeed in any risk-based arrangement, right? If care provided is consistently lower quality, uncoordinated, unsafe, or inefficient, how am I supposed to optimize my care delivery? Said another way, interoperability is essential for anybody who wants to succeed in a value-based arrangement. I need all the data on my patients, and I need it in a way that I can separate the signal from the noise. Of course, getting 40 pages of duplicative SOAP (subjective, objective, assessment, and plan) notes that are semi-accurate and that no one bothers to look at is just unhelpful. Quick counterpoint: FFS (fee for service) loves siloed data. You know how much money everybody talks about could be saved if we eliminate duplicative services? Well, that's how much some fee-for-service health system is gonna lose if you make it easy for clinicians to see that the patient already got that CAT scan. So, in sum, interoperability is essential to high-quality, safe, and efficient care. A mark of a health system or provider practice who is really committed to patient outcomes is going to be their commitment to share data. The world has moved from a “Hey, you're permitted to share data if you really want to” to a “You are obligated to share your data.” And right now, I am loosely quoting Micky Tripathi, PhD, MPP, who is the ONC's (Office of the National Coordinator for Health Information Technology) national coordinator and also the guy in charge of TEFCA (Trusted Exchange Framework and Common Agreement) and implementing the provisions against information blocking that was in the Cures Act Final Rule last year. In this healthcare podcast, I am speaking with the perfect person about interoperability, and that would be Lisa Bari, who is the CEO of Civitas Networks for Health, which is a national collaborative working to improve interoperability in this country to improve health. Since interoperability is a huge topic, what I wanted to understand from Lisa most particularly are: Who are the current roster of players in the interoperability space? Like, what is going on there? Lisa told me that there are four main groups of interoperability folks—EHR (electronic health record) systems; APIs (application programming interfaces); HIEs (health information exchanges), both profit and nonprofit; and then others like clearinghouses, etc—which we talk about in some detail in this episode. We also discussed Larry Ellison's bold proclamation that Cerner is going to build one national medical records database. It's almost like Larry made it through the “welcome to the healthcare briefing” packet that his team gave him and immediately concluded that the interoperability problem is a technology problem, not a business case, fee-for-service, workflow, no universal ID, human, organizational, or government problem. Lisa adds some fidelity there.  Also, TEFCA … we talk about what it is and what it's not. Short version: It's a framework so that no one can say they won't share data lest they get in trouble in some way. At the same time, it's not gonna solve, as Lisa puts it, “the last mile of interoperability,” meaning it's not going to put the right information in the right clinician's hands at the right time. It just governs getting data from one organization to another organization but kinda has nothing to do with the clinical workflow, so to speak. The Civitas Networks for Health annual conference, by the way, is coming up on August 21-24 if you are interested in going.  You can learn more at civitasforhealth.org.  Lisa Bari, MBA, MPH, is the inaugural CEO of Civitas Networks for Health, a national nonprofit member- and mission-driven organization that was previously known as the Network for Regional Health Improvement and the Strategic Health Information Exchange Collaborative. Civitas counts over 100 multi-stakeholder-governed regional health improvement collaboratives and health information exchanges as members and creates national opportunities for education and community building between its members, policy makers, and business partners. Their upcoming conference (August 21-24, 2022, in San Antonio or via livestream) focuses on the theme of data collaboratives and information exchanges creating the critical infrastructure for health equity. Previously, Lisa was the health IT and interoperability lead at the CMS Innovation Center, working on primary care innovation model policy, and additionally has a background in health IT marketing and strategy. She holds an MBA from Purdue University and a Master of Public Health in health policy from the Harvard TH Chan School of Public Health and serves on the boards of directors of HealthCare Access Maryland and the Zorya Foundation.  06:30 How does value-based care depend on interoperability? 07:38 Why is it really important to exchange information at the right time with the right purpose? 08:00 What is one of the easiest low-hanging fruit to achieve in value-based care? 09:42 What are the four kinds of companies getting into the interoperability space? 11:51 “As we know, there's sort of technical interoperability … and then there's semantic interoperability.” 12:59 Where are we right now with EHR basic interoperability? 15:33 Who should ACOs hire to get the right data at the right time? 17:00 Why is it important to delineate the different types of HIE? 22:09 What can ACOs assure with interoperability? 22:59 Is the demand among ACOs for interoperability there? 24:04 “If you're in value-based care, you better care about what's happening outside of the healthcare setting.” 24:36 EP108 with Chris Klomp.26:25 “Every couple of years, someone talks about creating the ultimate database to rule them all. … It hasn't happened yet, and I don't think it's going to happen.” 26:56 “The difficult thing about healthcare data … interoperability … is an organizational and a governance problem.” 28:49 “You've gotta start with the incentives … and then you do have to say … ‘We are not gonna hoard any more data.'” 29:10 What is TEFCA, and how does it fit into this interoperability conversation? 32:17 “I think partners are trying to solve for value and outcomes.” You can learn more at civitasforhealth.org.  @lisabari of @civitas4health discusses #interoperability on our #healthcarepodcast. #healthcare #podcast #digitalhealth How does value-based care depend on interoperability? @lisabari of @civitas4health discusses #interoperability on our #healthcarepodcast. #healthcare #podcast #digitalhealth Why is it really important to exchange information at the right time with the right purpose? @lisabari of @civitas4health discusses #interoperability on our #healthcarepodcast. #healthcare #podcast #digitalhealth What is one of the easiest low-hanging fruit to achieve in value-based care? @lisabari of @civitas4health discusses #interoperability on our #healthcarepodcast. #healthcare #podcast #digitalhealth What are the four kinds of companies getting into the interoperability space? @lisabari of @civitas4health discusses #interoperability on our #healthcarepodcast. #healthcare #podcast #digitalhealth “As we know, there's sort of technical interoperability … and then there's semantic interoperability.” @lisabari of @civitas4health discusses #interoperability on our #healthcarepodcast. #healthcare #podcast #digitalhealth Where are we right now with EHR basic interoperability? @lisabari of @civitas4health discusses #interoperability on our #healthcarepodcast. #healthcare #podcast #digitalhealth Who should ACOs hire to get the right data at the right time? @lisabari of @civitas4health discusses #interoperability on our #healthcarepodcast. #healthcare #podcast #digitalhealth Why is it important to delineate the different types of HIE? @lisabari of @civitas4health discusses #interoperability on our #healthcarepodcast. #healthcare #podcast #digitalhealth What can ACOs assure with interoperability? @lisabari of @civitas4health discusses #interoperability on our #healthcarepodcast. #healthcare #podcast #digitalhealth Is the demand among ACOs for interoperability there? @lisabari of @civitas4health discusses #interoperability on our #healthcarepodcast. #healthcare #podcast #digitalhealth “If you're in value-based care, you better care about what's happening outside of the healthcare setting.” @lisabari of @civitas4health discusses #interoperability on our #healthcarepodcast. #healthcare #podcast #digitalhealth “Every couple of years, someone talks about creating the ultimate database to rule them all. … It hasn't happened yet, and I don't think it's going to happen.” @lisabari of @civitas4health discusses #interoperability on our #healthcarepodcast. #healthcare #podcast #digitalhealth “The difficult thing about healthcare data … interoperability … is an organizational and a governance problem.” @lisabari of @civitas4health discusses #interoperability on our #healthcarepodcast. #healthcare #podcast #digitalhealth “You've gotta start with the incentives … and then you do have to say … ‘We are not gonna hoard any more data.'” @lisabari of @civitas4health discusses #interoperability on our #healthcarepodcast. #healthcare #podcast #digitalhealth What is TEFCA, and how does it fit into this interoperability conversation? @lisabari of @civitas4health discusses #interoperability on our #healthcarepodcast. #healthcare #podcast #digitalhealth “I think partners are trying to solve for value and outcomes.” @lisabari of @civitas4health discusses #interoperability on our #healthcarepodcast. #healthcare #podcast #digitalhealth   Recent past interviews: Click a guest's name for their latest RHV episode! Betsy Seals (EP375), Dave Chase, Cora Opsahl (EP373), Cora Opsahl (EP372), Dr Mark Fendrick (Encore! EP308), Erik Davis and Autumn Yongchu (EP371), Erik Davis and Autumn Yongchu (EP370), Keith Hartman, Dr Aaron Mitchell (Encore! EP282), Stacey Richter (INBW34), Ashleigh Gunter, Doug Hetherington, Dr Kevin Schulman, Scott Haas, David Muhlestein, David Scheinker, Ali Ucar, Dr Carly Eckert, Jeb Dunkelberger (EP360), Dan O'Neill, Dr Wayne Jenkins, Liliana Petrova, Ge Bai, Nikhil Krishnan, Shawn Rhodes, Pramod John (EP353), Pramod John (EP352), Dr Eric Bricker

Non Alcoholic Fatty Liver Disease (NAFLD) is on the rise. We sit down with Dr.Mayur Brahmania to discuss the causes and potential cures for this rapidly growing, but mostly unknown lifestyle driven disease. To purchase one of Tommy's Bestselling Books, follow the links below Heavy Brain: Behaviour Change for a Better Body https://amzn.to/3mucn89 The MetFlex-Rx Diet: https://amzn.to/3NBb438 Dr.Appleton's Website: https://andrewappletonmd.ca/ Dr.Brahmania is an Assistant Professor of Medicine at Western University practicing in Hepatology and Transplant Hepatology. He completed his undergraduate and medical degree at the University of Saskatchewan and eventually moved to Toronto for training in general and transplant Hepatology at the Toronto Centre for Liver Disease. He also earned a Masters of Public Health (MPH) degree at the Harvard TH Chan School of Public Health in Boston, MA. Mayur has been involved with the Choosing Wisely Canada (CWC) Locally, he is the program lead at Western for the Royal College's STARS (Students Advocating for Resource Stewardship) campaign to develop quality improvement learning and principles for Medical Schools in Canada. Dr. Brahmania is the current chair of the Gastroenterology Quality Improvement and Innovation Committee at Western University and currently focuses his research interests around quality improvement initiatives to advance and standardize quality of care in patients living with liver disease; He is currently Co-Director of the LHSC Healthcare Excellence Incubator, an innovative course where healthcare and IVEY business students learn together about quality improvement principles and implementation within a business framework.

Welcome back to Season 2, Episode 155 of the Asian Hustle Network Podcast! We are very excited to have Dr. Austin Chiang on this week's show. Honor AANHPI heritage, communities, and families today by getting vaccinated for a safer tomorrow. Vaccination greatly reduces your chance of having COVID symptoms like fatigue, pain, and memory problems that last for months. Protect your tomorrow with a vaccine today. Talk to a doctor if you have questions. Find vaccines and boosters near you at vaccines.gov. We can do this. Paid for by the U.S. Department of Health and Human Services. Dr. Chiang is the first Chief Medical Officer for the gastrointestinal business of Medtronic, the global leader in health technology. He is also currently an Assistant Professor of Medicine at Jefferson Health (Thomas Jefferson University Hospitals) in Philadelphia, PA, and serves as the Director of the Endoscopic Weight Loss Program and Chief Medical Social Media Officer for the health system. He completed his undergraduate studies at Duke University before earning his MD at Columbia University. He stayed for his Internal Medicine residency at New York-Presbyterian Hospital and completed his GI and bariatric endoscopy fellowships at Brigham and Women's Hospital. He obtained his MPH from the Harvard TH Chan School of Public Health before completing an advanced endoscopy fellowship at Jefferson. Passionate about empowering patients with accurate medical information online, he is one of the most influential voices in the field of gastroenterology across multiple social media platforms including Instagram, Twitter, TikTok, and YouTube with over 500,000 followers and over 130 million views. Dr. Chiang has conducted extensive research in social media and is a champion of physician presence on social media and is the Chief Medical Social Media Officer of Jefferson Health and Founding President of the Association for Healthcare Social Media (AHSM, @ahsm_org), the first 501(c)(3) professional society for health professional social media use. He has worked closely with all major national GI societies on social media efforts and was 2018's Healio Gastroenterology Disruptive Innovator of the Year, The Philadelphia Inquirer's 2019 Influencers of Healthcare Rookie of the Year, and among 2019 Medscape Top 20 Social Media Physicians, and a 2021 GLAAD Media Award Nominee. He spoke at South by Southwest (SXSW) 2021, and his role in social media has been featured by The New York Times, CNBC, and BBC News. He sits on the inaugural YouTube Health Advisory Board and in 2022, joined the White House Healthcare Leaders in Social Media Roundtable. To stay connected within the AHN community, please join our AHN directory: bit.ly/AHNDirectory --- Support this podcast: https://anchor.fm/asianhustlenetwork/support

What is the role of profit in healthcare and how can that incentive be used to create value for society and for patients? What can the medical curriculum learn from the business curriculum, and vice versa? In this episode, we answer all these questions and more with our guest, Elizabeth Kwo, MD. Elizabeth is the Chief Medical Officer at Everly Health, a healthcare company that aims to provide modern diagnostics-driven care. She is an experienced healthcare executive specialized in building and scaling digital healthcare products to provide high quality care, leveraging predictive and prescriptive analytics to improve outcomes. She is a physician at Cambridge Health Alliance, an affiliated teaching hospital of Harvard Medical School, and a lecturer for Harvard Medical School students and Preventive Care and Occupational Medicine residents. Dr. Kwo has an MD from Harvard Medical School, MBA from Harvard Business School, MPH from Harvard TH Chan School of Public Health, and a BA from Stanford University. She completed her residency at Harvard and is Board Certified in Preventive Care and Occupational Medicine.

While we do cancer clinical trials to test drugs, exposures that increase risks are found with observational studies. These have also been instrumental in highlighting disparities. Tim Rebbeck and Rafa Irizarry discuss the challenges these studies pose. Timothy Rebbeck, PhD is the Vincent L. Gregory, Jr. Professor of Cancer Prevention at the Harvard TH Chan School of Public Health and Professor of Medical Oncology at the Dana-Farber Cancer Institute. Dr. Rebbeck's research focuses on the etiology and prevention of cancer, with an emphasis on cancers with a genetic etiology and those that are associated with disparities in incidence or mortality by race. He has directed multiple large molecular epidemiologic studies and international consortia that have been used to identify and characterize genes involved in cancer etiology, understand the relationship of allelic variation with biochemical or physiological traits, explore interactions of inherited and somatic genomic variation with epidemiological risk factors. Our Data Science Zoominars feature interactive conversation with data science experts and a Q+A session moderated by Rafael A. Irizarry, PhD, Chair, Department of Data Science at Dana-Farber Cancer Institute.

Jenn speaks to Dr. Austin Chiang, the Director of Endoscopic Weight Loss Program and Chief Medical Social Media Officer at Jefferson Health and Chief Medical Officer at Medtronics. Dr. Chiang has been a pioneer using his social media presence to push for an awareness of encouraging more doctors and healthcare professionals to utilize social media to impact more people and public health. We talk about finding identity, and how to navigate the social media world we live in today, whether you are providing content or on the receiving end of information. How we should all try to remember the positive benefits of social media when used correctly and how to empower and advocate for others through it. (Recorded on August 13, 2021)About Dr. Chiang:Dr. Chiang is currently an Assistant Professor of Medicine at Jefferson Health (Thomas Jefferson University Hospitals) in Philadelphia, PA, and serves as the Director of the Endoscopic Weight Loss Program, Chief Medical Social Media Officer for the health system, and Chief Medical Officer at Medtronics. He completed his undergraduate studies at Duke University before earning his MD at Columbia University. He stayed for Internal Medicine residency at New York Presbyterian Hospital and completed his GI and bariatric endoscopy fellowships at Brigham and Women's Hospital. He obtained his MPH from the Harvard TH Chan School of Public Health before completing an advanced endoscopy fellowship at Jefferson.Passionate about empowering patients with accurate medical information online, he is one of the most influential voices in the field of gastroenterology across multiple social media platforms including Instagram, Twitter, TikTok, and YouTube with over 500,000 followers and over 130 million views. Dr. Chiang has conducted extensive research in social media and is champion of physician presence on social media and is the Chief Medical Social Media Officer of Jefferson Health and Founding President of the Association for Healthcare Social Media (AHSM, @ahsm_org), the first 501(c)(3) professional society for health professional social media use. He has worked closely with all major national GI societies on social media efforts and was 2018's Healio Gastroenterology Disruptive Innovator of the Year, The Philadelphia Inquirer's 2019 Influencers of Healthcare Rookie of the Year, and among 2019 Medscape Top 20 Social Media Physicians, and a 2021 GLAAD Media Award Nominee. He spoke at South by Southwest (SXSW) 2021, and his role in social media has been featured by The New York Times, CNBC, and BBC News.Episode Resources:Website ASHM IG Youtube Twitter Tiktok 

Dr. Deirdre Tobias joins us to talk about the relationship between diet, obesity, and health, with a focus on the role of processed foods. Dr. Tobias is an epidemiologist who specializes in nutrition, obesity, and methods. She is an Assistant Professor in the Department of Nutrition at the Harvard TH Chan School of Public Health and at Brigham and Women's Hospital in Boston. This episode explores the following questions: - What are (ultra) processed foods? - What do we know about the link between food processing and obesity and related diseases? What do we not yet understand? - What are the limitations of the "whole is good and processed is bad" food rule? - How can we translate nutrition science into actionable advice for the public?  Drs. Tobias and Davis also share practical tips for how they shop and prepare foods for their families in a way that leverages the advantages of processed foods while ensuring high nutritional value. More from Dr. Deirdre Tobias at Harvard and on Twitter. Resources The Harvard Nutrition Source https://www.hsph.harvard.edu/nutritionsource/ Studies Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake https://pubmed.ncbi.nlm.nih.gov/33027677/ Eliminate or reformulate ultra-processed foods? Biological mechanisms matter https://pubmed.ncbi.nlm.nih.gov/34699743/ The energy balance model of obesity: beyond calories in, calories out https://pubmed.ncbi.nlm.nih.gov/35134825/ Ultra-processed food consumption and excess weight among US adults https://pubmed.ncbi.nlm.nih.gov/29729673/

Dr. Deirdre Tobias joins us to break down how nutrition research is done and how it's translated, or mis-translated, into health headlines.   The goal of this episode is to help you navigate flip-flopping nutrition headlines using practical tips and a basic understanding of nutrition research. Buckle up for a candid look at different types of studies, and a discussion of key concepts like causation, confounders and chance (p values).   Dr. Tobias is an epidemiologist who specializes in nutrition, obesity, and methods. She is an Assistant Professor in the Department of Nutrition at the Harvard TH Chan School of Public Health and at Brigham and Women's Hospital in Boston. More from Dr. Deirdre Tobias at Harvard and on Twitter. Resources: The Harvard Nutrition Source https://www.hsph.harvard.edu/nutritionsource/  

Tamarra James-Todd, PhD is an Associate Professor of Environmental Health at the Harvard TH Chan School of Public Health. She tells me about the motivations for her research interests in environmental reproductive justice, dedicating her diabetes research to her late father, the value of peer mentorship, joy riding with her dad in his Mustang in the '70s, dinner with Hannibal Lecter and Molly Ringwald, and more! Laugh along with us!Support the show (https://www.patreon.com/shinyepipeople)

Are you curious about a career in Population Health Management? Then you'll want to listen to today's episode with Elizabeth Fonseca, Program Director for Population Health Management at Mass General. In this capacity, she directs a portfolio of programs focused on redesigning care to increase value. Elizabeth leads a team of project managers and care navigators in implementing a suite of programs across the care continuum- spanning the primary care, specialty care, post-acute care, and home-based care settings- as well as the transitions in between those care settings. In our conversation, we discuss what led her into this career pathway, how she works with departmental leadership to implement visions that transform healthcare, the most important project management skills one should focus on and so much more. What I love about our conversation is that she drops so many tangible actions steps you can take and start applying now!  Elizabeth holds a Master of Science in Global Health and Population from the Harvard TH Chan School of Public Health and a Bachelor of Arts in Psychology (Honors) from Boston College. In addition to health, Elizabeth has a keen interest in education. She is a certified teacher of English as a Foreign Language and serves as a tutor/mentor to students and young professionals in the greater Boston area. Key Takeaways: 2:06 - Career background & the importance of volunteering 5:40 - Pathway to becoming Program Director @ Mass General 14:40 - How to know when a role isn't the right fit for you 18:05 - Defining population health management/ day in the life 21:35- Implementing a vision 24:50- The art of asking great questions 27:51- Project management skill sets that are important and how to build them 31:00 - Tailored Project management course created by Elizabeth 35:25 - How to engage clinical leaders in population health management 38:25- Projects that have made a large impact 45:30 - Rapid fire and closing Post a screenshot of you listening on Instagram and tag us (@thehealthcareleadershipmindset & @yolanda_gonzalez11) so we can thank you personally!  Connect with Elizabeth via LinkedIn: https://www.linkedin.com/in/elizabethcafierofonseca/

Sally Powell Price joined MilliporeSigma in 2020 as a Regulatory Expert for Food Safety Testing for North America. Previously, she served as Director of Lab Operations at a biotech startup in Boston and was a Food Lab Supervisor at the New York City Department of Health - Public Health Laboratory.  She has a bachelor's degree in Biology, a master's in Microbiology & Immunology, and did continuing coursework in public health and foodborne disease at Harvard TH Chan School of Public Health. She's a member of the Association of Food and Drug Officials (AFDO), American Public Health Association, Association of Public Health Laboratories, and AOAC.  Justyce Jedlicka currently serves as the Food and Beverage Regulatory Liaison in North America for MilliporeSigma. Responsible for engaging with influencers in the food and beverage industry to align initiatives to be in the highest regulatory compliance and promote best practices among testing methods promoting the safest and highest quality food, Justyce has been serving the food and beverage industry since 2013. She received her BS in Chemistry and MBA from the University of Missouri in St. Louis. She currently serves on the Food Sciences Section Executive Board of the American Council of Independent Labs and is a member of IAFP, ISBT, and AOAC. In this BONUS episode of Food Safety Matters we speak with Sally and Justyce about: Where do mycotoxins come from?  Why mycotoxins are a concern in the food space Contributing factors to the rising concern of mycotoxins How mycotoxins are controlled from a regulatory standpoint Recommended resources for those interested in understanding the regulatory landscape Commodities where mycotoxin analysis is becoming increasingly relevant Sampling and testing challenges some might experience with Mycotoxins? How customers can leverage companies like MilliporeSigma to maintain compliance References: Association of American Feed Control Officials AOAC's Cannabis Analytical Science Program FDA's Chemical Hazards Resource Page Sponsored by: MilliporeSigma We Want to Hear from You! Please send us your questions and suggestions to podcast@foodsafetymagazine.com  

Sally Powell Price joined MilliporeSigma in 2020 as a Regulatory Expert for Food Safety Testing for North America. Previously, she served as Director of Lab Operations at a biotech startup in Boston and was a Food Lab Supervisor at the New York City Department of Health - Public Health Laboratory.  She has a bachelor's degree in Biology from Hamilton College, a master's in Microbiology & Immunology from James Cook University in Australia, and did continuing coursework in public health and foodborne disease at Harvard TH Chan School of Public Health. She's a member of the Association of Food and Drug Officials (AFDO), American Public Health Association, Association of Public Health Laboratories, and AOAC.  Justyce Jedlicka currently serves as the Food and Beverage Regulatory Liaison in North America for MilliporeSigma. Responsible for engaging with influencers in the food and beverage industry to align initiatives to be in the highest regulatory compliance and promote best practices among testing methods promoting the safest and highest quality food, Justyce has been serving the food and beverage industry since 2013. She received her BS in Chemistry and MBA from the University of Missouri in St. Louis. She currently serves on the Food Sciences Section Executive Board of the American Council of Independent Labs and is a member of IAFP, ISBT, and AOAC. In this BONUS episode of Food Safety Matters we speak with Sally and Justyce about: Where do mycotoxins come from?  Why mycotoxins are a concern in the food space Contributing factors to the rising concern of mycotoxins How mycotoxins are controlled from a regulatory standpoint Recommended resources for those interested in understanding the regulatory landscape Commodities where mycotoxin analysis is becoming increasingly relevant Sampling and testing challenges some might experience with Mycotoxins? How customers can leverage companies like MilliporeSigma to maintain compliance References: Association of American Feed Control Officials AOAC's Cannabis Analytical Science Program FDA's Chemical Hazards Resource Page Sponsored by: MilliporeSigma We Want to Hear from You! Please send us your questions and suggestions to podcast@foodsafetymagazine.com  

Dr. Michael Mina is the newly appointed Chief Science Officer at eMed and a former Assistant Professor of Epidemiology as well as Immunology and Infectious disease at Harvard TH Chan School of Public Health. Dr. Mina earned his MD and PhD from Emory University, with postdoctoral fellowships at Princeton University and Harvard Medical school. He completed his residency training in clinical pathology at Brigham and Women's Hospital before joining the faculty of Harvard. Today, Dr. Mina shares his incredible journey from undergrad to Buddhist monk to MD-PhD student to Assistant professor, with stops in Sri Lanka, Nicaragua, and South Africa. Credits: Our deepest thanks to Dr. Mina for joining us today! Dr. Mina's Faculty Page: https://www.emed.com/michael-mina?hsLang=en Follow Dr. Mina on Twitter: @michaelmina_lab Host: Bejan Saeedi Co-Host and Audio Engineer – Joe Behnke Executive Producer and Social Media Coordinator – Carey Jansen Executive Producer – Michael Sayegh Faculty Advisor – Dr. Brian Robinson Twitter: @behindthescope_ Instagram: @behindthemicroscopepod Facebook: @behindthemicroscope1 Website: behindthemicroscope.com

Fragmented health care is a known issue for patients and providers, and nowhere is the problem as acute as it is in the over-65 population. Studies have shown that patients who have a strong relationship with a primary care provider (PCP) who coordinates their care have better outcomes. But care provided by specialists has expanded over the past 2 decades, and the average PCP has twice as many specialists involved in the care of their fee-for-service Medicare patients as they did 20 years ago, according to research published in Annals of Internal Medicine this week. On this episode of Managed Care Cast, we speak with one of the coauthors of the study, "Trends in Outpatient Care for Medicare Beneficiaries and Implications for Primary Care, 2000 to 2019," which illustrates the changing trends in a PCP's panel of Medicare patients and how that translates to an increased workload for primary care doctors. Michael L. Barnett, MD, MS, an assistant professor in the Department of Health Policy and Management at the Harvard TH Chan School of Public Health, is also an assistant professor of medicine at Brigham and Women's Hospital in Boston. He earned his medical degree from Harvard Medical School and holds a master of science in health policy and management from the Harvard TH Chan School of Public Health.

It is pretty difficult to convey all of your thoughts and feelings in just 3 minutes. However that is all the time I had when I addressed the CCS Board on August 9th. And while I can't even begin to address everything in this Podcast episode, I can at least breakdown my speech a little to bring more context and understanding to my perspective.  SOURCES: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7580955/ Let Them Breathe Organization https://www.letthembreathe.net/schools Phewwww, the CDC is mostly on target in rules for reopening school this fall. Joseph G. Allen, Harvard TH Chan School of Public Health, USA Today, July 9, 2021. The Kids Are Alright: Why now is the time to rethink COVID safety protocols for children – and everyone else. New York Magazine, July 12, 2021. Kids, Covid and Delta: A guide to help parents . New York Times, June 18, 2021. It's time for children to finally get back to normal life. Dr. Tracy Beth Hoeg, UC Davis; Dr. Lucy McBride; Dr. Allison Krug; Dr. Monica Gandhi, UCSF. Washington Post, May 30, 2021. What Really Happened With that Weird Yankees COVID Outbreak. New York Magazine, May 19, 2021. Is a Mask That Covers the Mouth and Nose Free from Undesirable Side Effects in Everyday Use and Free of Potential Hazards? International Journal of Environmental Research and Public Health, April 2021. Why a Mask is Not Just a Mask. Global Mental Health Programs, Columbia University, April 17, 2020. Their Tank is Empty. Mental Health Trouble https://www.cpr.org/2021/05/25/covid-mental-health-childrens-hospital-colorado/ Dr. Amesh Adalja on CSPAN https://www.c-span.org/video/?509562-3/washington-journal-dr-amesh-adalja-discusses-us-covid-19-pandemic-response Science: MVCSC School Board Meeting - 8/6/21: 15 minute mark Dr. Dan Stock https://www.youtube.com/watch?v=AUjkSaedN4g6 Strong Schools ToolKit https://covid19.ncdhhs.gov/media/164/open

Today's episode is presented by the American Case Management Association. Join our host, Deb McElroy, along with featured guest, Dr. Vikram Patel. Dr. Patel is the Pershing Square Professor of Global Health and Wellcome Trust Principal Research Fellow at the Harvard Medical School. He is a psychiatrist whose work over the past two decades has focused on addressing the vast unmet needs for mental health care, especially in low resourced settings. He holds honorary professorships at the Harvard TH Chan School of Public Health, the Public Health Foundation of India, and the London School of Hygiene & Tropical Medicine. The pandemic has led to an economic downturn and associated increase in the prevalence of mental health problems globally and considerably worsened the pre-existing crisis of unmet need for care. Dr. Patel argues this presents a historic opportunity to reimagine mental health care, by scaling interventions designed to improve the access, quality, and person-centered features of care. Several programs are discussed throughout this discussion, including the Mental Health for All Lab, the Global Mental Health Initiative at Harvard and Sangath. Resources referenced by Dr. Patel include: EMPOWER program - www.empower.care This is a not-for-profit effort of Harvard Medical School's GlobalMentalHealth@Harvard initiative to build the community based mental health workforce. Mental Health for All Lab - https://mentalhealthforalllab.hms.harvard.edu/This provides information about the research program led by Dr. Patel at Harvard. RAND Corporation report on transforming mental health in the U.S. - https://www.rand.org/pubs/research_reports/RRA889-1.html Join thousands of your peers who have made the decision to further their connections, learning and knowledge afforded through ACMA membership. Gain access to resources like the Collaborative Case Management Journal, a bimonthly, peer-reviewed digital journal dedicated to all things case management and transitions of care; available exclusively to ACMA Members. Visit www.acmaweb.org/membership to learn more. Please visit acmaweb.org/podcast for more information about the podcast, or contact us directly at podcast@acmaweb.org with questions, topic requests, or other feedback.

Dr. Abdul El-Sayed is a physician, epidemiologist, educator, author, speaker, and podcast host. We first met back in 2017 while I was competing in a pitch competition for a start-up I had at the time, Abdul was the keynote speaker. He told an incredible story about his time as Detroit's Health Director, where he often worked directly with kids who faced uncertain futures because of the health risks present in the communities. From that moment on, I've been a huge fan of Abdul's work and his overall outlook on life. Better yet, only a few days prior to that speech he announced his historic candidacy for the Governor of Michigan, which would have seen him become America's first Muslim governor. While he didn't win this race, he earned tremendous support from progressives all over the country led by Bernie Sanders and Alexandria Ocasio-Cortez and touched the lives of thousands of people across Michigan and beyond with his vision for a better future and his unique brand of progressivism. Abdul and I have stayed in touch over the years and I'm always inspired by his ability to capture and articulate the moment, and help chart a collective path forward. In this episode, we talk about the role that travel plays in developing and defining one's identity. He shares his experiences traveling between the United States and Egypt as a child and how these trips continue to shape his life today. We also talk about his time living in the United Kingdom as a graduate student, and what lessons from abroad he's been able to bring home to Michigan. We touch on his 2018 run for the Governor of Michigan, his reflections and current thoughts on the Covid-19 pandemic, and what the future of travel looks like as we begin to engage in exploration again. We end the conversation in a similar manner to when I first met Abdul, with him speaking about the future of the progressive movement and where he views his role going forward. Follow along with Abdul's work: His newsletter, "The Incision," cuts to the heart of the trends shaping our moment. He is a commentator at CNN. His two books include "Healing Politics," calling for a politics of empathy to cure our epidemic of insecurity, and "Medicare for All: A Citizen's Guide" with Dr. Micah Johnson. He is the host of “America Dissected,” a podcast by Crooked Media, which goes beyond the headlines to explore what really matters for our health. He is a Senior Fellow at the FXB Center for Health & Human Rights at the Harvard TH Chan School of Public Health, and a Scholar-in-Residence at Wayne State University and American University, teaching at the intersection of public health, public policy, and politics. He is formerly the Health Director for the City of Detroit and candidate for governor of Michigan in 2018. Follow Abdul on Instagram and Twitter. Support the Show: Visit: www.techawat.com Paypal: paypal.me/BenjaminMorse Instagram: @techawat_with_benjamin_morse, @benjamin_august_blair Original Music by Elly Daftuar, connect on Instagram: @elecaster Logo by Jeff Butler, connect on Instagram: @butlejef2 --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app Support this podcast: https://anchor.fm/techawat-benjamin-morse/support

Dr. Tobias is a nutrition and obesity epidemiologist at the Brigham and Women’s Hospital and Harvard Medical School in Boston, MA. She received doctoral and postdoctoral training from the Harvard TH Chan School of Public Health, Boston, MA, under mentor Dr. Frank B. Hu. Dr. Tobias is co-Instructor of Nutrition Epidemiology with Dr. Walter Willett and faculty member at the Harvard TH Chan School of Public Health. Her epidemiologic research focuses on identifying lifestyle risk factors and underlying mechanisms related to obesity and its major chronic diseases, including type 2 diabetes and cancer. Dr. Tobias is currently the Academic Editor for the American Journal of Clinical Nutrition. Show notes at sigmanutrition.com/episode386

In this episode of "Keen On", Andrew is joined by Harriet A. Washington, the author of "Carte Blanche", to tackle the ethical issue of medical consent being abused in America. Unfortunately, minority groups and people of color are the most egregiously taken advantage of, even within the medical field and by those with a duty of care. Harriet A. Washington is a prolific science writer, editor and ethicist who is the author of the seminal Medical Apartheid: The Dark History of Experimentation from Colonial Times to the Present, which won a National Book Critics Circle Award, the PEN/Oakland Award, and the American Library Association Black Caucus Nonfiction Award and five other well-received books, including A Terrible Thing to Waste: Environmental Racism and Its Assault on the American Mind as well as the forthcoming Carte Blanche: The Erosion of Informed Consent in Medical Research , will be published in 2021 by Columbia Global Reports. She is a Fellow of the New York Academy of Medicine, has been the 2015-2016 Miriam Shearing Fellow at the University of Nevada's Black Mountain Institute, a Research Fellow in Medical Ethics at Harvard Medical School, Visiting Fellow at the Harvard TH Chan School of Public Health, a visiting scholar at DePaul University College of Law and a senior research scholar at the National Center for Bioethics at Tuskegee University. She has also held fellowships at Stanford University and teaches bioethics at Columbia University, where she delivered the 2020 commencement speech to Columbia’s School of Public Health graduates and won the 2020 Mailman School Of Public Health’s Public Health Leadership Award, as well as the 2020-21Kenneth and Mamie Clark Distinguished Lecture Award. Ms. Washington has written widely for popular publications and has been published in refereed books and journals such as Nature, JAMA, The American Journal of Public Health, The New England Journal of Medicine, the Harvard Public Health Review, Isis, and The Journal of Law, Medicine, and Ethics. She has been Editor of the Harvard Journal of Minority Public Health, a guest Editor of the Journal of Law, Medicine and Ethics and served as a reviewer for the Journal of the American Association of Bioethics and the Humanities. Ms. Washington has also worked as a classical-music announcer for public radio and curates a medical-film series. Learn more about your ad choices. Visit megaphone.fm/adchoices

From flight bans, entry bans, compulsory quarantine and virus testing, most countries have introduced travel restrictions in an effort to control the spread of the virus. But for a virus that knows no borders, do cross border health measures actually work? Claudia Hammond and her panel of global experts answer listeners’ questions and discuss the very latest science about the use of border controls in this pandemic. The countries we can all learn from, researchers say, include Singapore, Australia, New Zealand, Taiwan, Vietnam, Thailand and South Korea. Their border policies are said to be consistent and crucially, integrated with strong domestic public health measures. So while we wait for vaccinations, it seems an international vaccination passport will be rolled out very soon, maybe as early as Spring. A digital passport – a golden ticket to travel – could give privileged access to those who have been inoculated. But what are the ethical and scientific concerns of such a move? The panel with the answers include Kelley Lee, Professor of Public Health at Simon Fraser University in British Columbia, Canada who is leading an international project to assess cross border health measures, Pandemics and Borders, Dr Voo Teck Chuan, Assistant Professor at the University of Singapore Centre for Biomedical Ethics and a member of the WHO Working Group on Ethics and Covid-19, Dr Birger Forsberg, Associate Professor of International Health at the Karolinska Institute in Sweden and senior physician and health planner at the regional health authority of Stockholm and Marc Lipsitch, Professor of Epidemiology at the Harvard TH Chan School of Public Health and Director of the Centre for Communicable Disease Dynamics in the USA. Produced by: Fiona Hill, Samara Linton and Maria Simons Editor: Deborah Cohen Technical Support: Sarah Hockley

Sally Powell Price joined MilliporeSigma earlier this year as a Regulatory Expert for Food Safety. Previously, Sally served as the Director of Lab Operations at a biotech startup in Boston supporting regulatory & R&D operations. Prior to that role, she was the Food Lab Supervisor at the New York City Department of Health, Public  Health Laboratory. Sally is a member of the Association of Food and Drug Officials, American Public Health Association, Association of Public Health Laboratories, and AOAC. She has a B.Sc. degree in biology from Hamilton College, and a M.Sc. in microbiology & immunology from James Cook University in Australia, and continuing coursework in public health and foodborne disease at Harvard TH Chan School of Public Health. Justyce Jedlicka currently serves in the newly created role of the Food and Beverage Regulatory Liaison in North America for MilliporeSigma. She is responsible for engaging with influencers in the food and beverage industry to align initiatives to be in the highest regulatory compliance and promote best practices among testing methods—promoting the safest and highest quality food. Prior to MilliporeSigma, she worked as a formulation chemist and lab technician at Chemia Corporation. She currently serves on the Food Sciences Section Executive Board of the American Council of Independent Labs. She is a member of the International Association of Food Protection, Institute of Beverage Technologists, and participates in working groups with AOAC. Justyce received a B.Sc. in chemistry and an M.B.A. from the University of Missouri in St. Louis. ​In this BONUS episode of Food Safety Matters, we speak to MilliporeSigma about: Why are we seeing so many Salmonella outbreaks? Why Salmonella is so difficult to irradicate in the processing environment How to use FDA’s new outbreak tool Steps the food industry is taking to control Salmonella Choosing the correct kill steps for Salmonella How the industry is communicating with consumers about Salmonella The importance of food safety advocacy groups Regulatory updates surrounding Salmonella What are multi-drug resistant Salmonella and why are they important to understand What the future holds for controlling and irradicating Salmonella  What makes MilliporeSigma’s Salmonella control products different  Advice for the food industry in controlling Salmonella  How Salmonella is affecting the pet food industry Resources: Safe Solutions for Food and Beverages EN ISO 6579-1 for Salmonella Detection in the food chain Presenting Sponsor: MilliporeSigma

Millions of us, across the world, are subject to curfews, stay-at-home orders and lockdowns but what makes us stick to the rules, bend them or ignore them altogether? Claudia Hammond and her expert panel of guests consider the psychology of following the rules. Leading social psychologists share research which show that higher levels of trust in leadership translates to more pandemic guidance followed. A sense of “We” not “I”, a shared identity, makes a difference too, as well as identification with the whole of humankind, not just your immediate family. But there is danger too, from a “narrative of blame”, where individuals are demonised if they break the rules. Such an approach, Claudia hears, is corrosive to the all-important sense of shared identity and alienates some groups, while making others complacent. Also in the programme, what impact can rapid “have you got it” antigen tests which give results in minutes, rather than days, have on the virus? Claudia hears from the Cameroon in Central, West Africa, one of the first countries in the world to try mass testing using these rapid diagnostic tests. And she talks to scientists at the forefront of evaluating and modelling how their use could affect transmission of the virus, and daily life for all of us, until a vaccine is available. This month, Claudia’s panel of specialists answers BBC World Service listeners’ questions and includes Professor Michael Mina, Assistant Professor of Epidemiology Immunology and Infectious Diseases at Harvard TH Chan School of Public Health in USA, Dr Margaret Harris, from the World Health Organisation in Geneva, Switzerland, Steve Reicher, Professor of Social Psychology at St Andrews University in Scotland, Professor Rolf Van Dick, social psychologist and Vice President of the Goethe University in Frankfurt, Germany and Dr Jilian Sacks, senior scientific officer for Pandemic Preparedness for FIND, the Foundation for Innovative New Diagnostics in Geneva.

Speaker: William Overholt, Senior Research Fellow, Harvard Kennedy School. Moderator: Lawrence H. Summers, Charles W. Eliot University Professor and President Emeritus, Harvard University; Secretary of the Treasury for President Clinton; Director of the National Economic Council for President Obama. Introduction by: Winnie Chi-Man Yip, Professor of Global Health Policy and Economics, Department of Global Health and Population; Faculty Director, Harvard China Health Partnership, Harvard TH Chan School of Public Health; Interim Director, Fairbank Center for Chinese Studies. Co-sponsored by the Fairbank Center for Chinese Studies and the Mossavar-Rahmani Center for Business & Government, Harvard Kennedy School.

As the blueberry industry can attest, health research has been vital to the growth of the global blueberry market. While we've touched on blueberry health research in past episodes, it's time to do a deep dive to better understand the current and potential health research that has been so critical to increased demand for blueberries.. Host Kasey Cronquist, USHBC and NABC president, is joined by Eric Rimm, Sc.D., professor of epidemiology and nutrition, director of the program in cardiovascular epidemiology at the Harvard TH Chan School of Public Health, and professor of medicine at Harvard Medical School. Rimm also sits on the USHBC Health Research Committee science advisory board.  “This study would not have been possible, not just for the packets, but this was actually funded by the USHBC.” - Eric Rimm, Sc.D. “Blueberries can actually be there for swapping something out of breakfast, it can be a side for a lunch or a dinner, and it could be a replacement for dessert. Where you still get all of the satisfaction of (taking) out something, but you still get to put blueberries in.” - Eric Rimm, Sc.D.  Topics covered include:  Results and methods of the latest clinical trial with blueberries. Difficulties of a large-scale study. The concept of healthy swaps. The difference between “fad” diets and the research USHBC funds.  The next frontier for blueberry health research.  Crop Report - October 21, 2020  The Blueberry Crop Report is an update on crop conditions and markets throughout North America. In this episode, you'll hear from Andres Armstrong in Chile, Luis Vegas in Peru, and Jose Luis Bustamante in Mexico. This was recorded October 2020.

Edward L. Barnes, MD is currently an Assistant Professor of Medicine in the Division of Gastroenterology and Hepatology at the University of North Carolina. Dr Barnes completed his residency in internal medicine at the University of North Carolina, where he also served as a chief resident. He completed his gastroenterology fellowship at Brigham and Women's Hospital in Boston, Massachusetts. While training in Boston, he earned Master of Public Health degree from the Harvard TH Chan School of Public Health. Dr. Barnes then returned to the University of North Carolina to complete an Advanced Fellowship in Inflammatory Bowel Diseases. He specializes in the care of patients with inflammatory bowel disease, and has contributed multiple articles and reviews in this area. What gets you up in the morning? Furthermore, what wakes you up in the middle of the night? Today, Dr. Edward Barnes shares why balancing your time combined with your passion is a winning combination for success. To avoid burnout, we must adapt strong time management skills early on in the game. On top of that, we must place importance on career paths that fit who we are—so we're not forcing ourselves into something that isn't in alignment with ourselves. He urges us to think with an open mind, embrace rejection as part of the process, and get comfortable with “prioritizing things in your bucket of tasks”. Pearls of Wisdom: 1. Find a career that fits who you are. 2. Find that one thing that excites you to wake up every morning or in the middle of the night. Approach each opportunity with an open mind and think outside the box. 3. Know how to prioritize things in your bucket of tasks. Find the right balance and know when to prioritize what and anticipate that there will be moments in your life when you will have to shift around the things in your bucket. 4. Find the match between your goals and the mentors in your life.

In this episode of Causes or Cures, Dr. Erin Stair chats with Dr. John McDonough about Medicare for All. They discuss what the slogan really means, the details of Medicare, who would be covered, what role private insurance companies would play, quality of care, personal values, how much it would cost over ten years and who will pay for it. Dr. McDonough is a professor of practice at the Harvard TH Chan School of Public Health in the Department of Health Policy & Management and Director of the HSPH Center for Executive & Continuing Professional Education. Between 2008 and 2010, he served as a Senior Advisor on National Health Reform to the U.S. Senate Committee on Health, Education, Labor and Pensions where he worked on the writing and passage of the Affordable Care Act. Between 2003 and 2008, he was Executive Director of Healthcare For All, a Massachusetts consumer health advocacy organization, where he played a leading role in the passage of the 2006 Massachusetts Health Reform Law. From 1998 through 2003, he was an associate professor at the Heller School at Brandeis University. From 1985 to 1997, he was a member of the Massachusetts House of Representatives where he co-chaired the Joint Committee on Health Care. His articles have appeared in the New England Journal of Medicine, Health Affairs and other journals. He has written: Inside National Health Reform in 2011 and Experiencing Politics: A Legislator’s Stories of Government and Health Care in 2000, both by the University of California Press and the Milbank Fund, and Interests, Ideas, and Deregulation: The Fate of Hospital Rate Setting in1998 by the University of Michigan Press. He holds a doctorate in public health from the University of Michigan and a master’s in public administration from the Kennedy School of Government at Harvard. To get in touch with Dr. Erin Stair, please visit her website, Blooming Wellness.To follow her on Instagram, click here.To find her on Twitter, click here.To follow her health page on Facebook, click here.To read or listen to her new comedic parody on the wellness industry, Yours in Wellness, Krystal Heeling, click here.To read Manic Kingdom, click here.

Dr. Caroline Buckee, an epidemiologist with the Harvard TH Chan School of Public Health, sits down with Dr. Chana Davis to talk about navigating risk in the midst of a pandemic. We are all asking the same questions: Is it worth the risk? What can I do to mitigate risk? What will happen if I get COVID? Whether you're grappling with back-to-school, birthday parties, haircuts, fitness classes, or grocery shopping, science can help you answer your questions with confidence. Dr. Buckee shares the latest science on COVID-19 transmission, severity, and immunity. She explains some of the ways we can all make use of public health data, while recognizing its limitations. Lastly, Buckee discusses the key factors that will shape the next six months of this pandemic including vaccines, herd immunity, and ... politics. Together, Buckee and Davis reflect on the science of science - how the COVID pandemic has provided a rare glimpse of the dynamic nature of science, and how we, and our COVID models, are still learning. NOTE: This video was filmed on 24 August 2020 and all information was up-to-date as of that date. Dr. Caroline Buckee is an Associate Professor of Epidemiology and Associate Director of the Centre for Communicable Disease Dynamics at Harvard's School of Public Health. She and her colleagues have played, and continue to play, critical roles in understanding the COVID-19 pandemic and informing public health policies. Get Real Health provides science-based insights so that you can make smart, healthy choices. Dr. Chana Davis (PhD, Stanford genetics) interviews leading experts who share practical, science-based advice and bust common myths and misconceptions. Show topics span food (nutrition, toxicology, weight loss), exercise, infectious diseases (microbiome, COVID-19), public health (vaccines), and mental wellbeing.

Aaron David Miller of Carnegie Endowment on United Arab Emirates and Israel. Laura Meyerson of Univ of Rhode Island on the mysteriously mailed seeds. Walter Willett of Harvard TH Chan School of Public Health on how healthy milk is. Howard Henderson of Texas Southern Univ on police and race. Douglas Fields on his new book "Electric Brain". Jeff Schlegelmilch of Columbia Univ on his new book "Rethinking Readiness: A Brief Guide to Twenty-First-Century Megadisasters".

Dr. Shaniece Criss “The world will tell you what success looks like, but truly success looks differently for different people.” The words of Dr. Shaniece Criss. She has defined her own success by fulfilling purpose in three main areas: government, media, and academia. And she has succeeded in all three. She was the first African American female to be elected to the Travelers Rest City Council in the Upstate. She is an assistant professor of Health Science at Furman University. And as a public health practitioner, Dr. Criss served as producer and host for a national television show for the Ministry of Health in Guyana, South America, during her Peace Corps service. She received her Doctor of Science degree from Harvard TH Chan School of Public Health. At the Harvard Kennedy School of Government, she was awarded a Presidential Public Service Fellowship. She serves on the board of directors for Prisma Health, Public Education Partners, Dining for Women and SC YMCA Youth in Government and

At the end of the day, health care should be about helping patients find their way to health while doctors, nurses, and other clinicians don’t burn out in the process. It’s becoming increasingly indisputable that the way to get to this North Star efficiently is through human-centered health care. Human-centered health care is a term coined by Dr. Sylvia Romm, and it’s a play on the term customer-centered design. How do we innovate? How do we use technology to intensify the human experience for both provider and patient? How do we rid ourselves of friction points and create a continuum of care that is sticky and makes getting healthy as enjoyable as Instagram? In this health care podcast, I speak with Sylvia Romm. She’s an MD and an MPH with a background as a researcher and a telemedicine entrepreneur prior to coming to Atlantic Health System as their chief innovation officer. We talk in this podcast about human-centered health care—what this means, what the success factors are, and how to make it happen. We also take into account the assorted challenges to overcome on the way there. This interview was recorded moments before COVID-19, and I say that as a good thing. Dr. Romm brings up telehealth as, let’s just say, a first step toward actuating human-centered design in health care. Clearly in the past, that was quite a hurdle. No longer. So, those health systems or you other stakeholders in the mix who have gotten the telehealth thing nailed, listen on for ways that you can leverage your success. And for those of you who haven’t, well, here’s a little extra motivation. You can learn more by connecting with Dr. Romm on Twitter at @sylvia_romm.  Sylvia Romm, MD, MPH, is driven by a passion for transforming health care delivery to patients and communities. She brings her background and expertise as a clinician and an entrepreneur to her role as chief innovation officer for Atlantic Health System. Firmly believing that a patient-centered focus is vital to health care innovation, Dr. Romm works with Atlantic Health System’s team members and physicians to find new ways to improve access to high-quality, affordable care. She also forges relationships with local and national innovation partners and works to expand the organization’s research profile. Dr. Romm is an avid author and speaker in the areas of health care, technology, and health information technology (IT) policy. She has written articles for various publications—including NEJM Catalyst, Forbes, KevinMD, and the Huffington Post—and was named one of Fierce Healthcare’s 8 Influential Women Reshaping Health IT and Becker’s Women in Health IT to Watch in 2020. A board-certified pediatrician, Dr. Romm has served in a variety of clinical leadership roles throughout her residency and as a hospitalist. Before joining Atlantic Health System, she was vice president of clinical transformation for American Well, the largest video-based telemedicine company in the United States. In addition, she was the founder of MilkOnTap, the nation’s first telehealth company focused on the needs of nursing mothers and lactation support. Dr. Romm earned her Master of Public Health in global health from Harvard TH Chan School of Public Health. She holds a medical degree from the University of Arizona College of Medicine and completed her residency in pediatrics at Massachusetts General Hospital. 02:18 How Dr. Romm’s background in research, public policy, and being a pediatric hospitalist intertwine to create great innovation strategies. 03:22 “How do we look at populations?” 03:31 “It’s really about affecting the system in its entirety.” 04:33 What human-centered health care means. 06:36 “You’re only as effective as the rapport that you build with [this] person.” 08:05 “What do people really need … but also, what do they find valuable?” 09:42 How data are folded into human-centered health care. 11:55 “The endgame is to figure out … how to have a better experience.” 12:39 How this fits into the quadruple aim. 17:19 “We are going to have to earn and learn agility.” 19:38 What has the most promise in deepening the connection between patients and providers. 20:32 “Is this about you, and how do we know … how people outside feel about creating a relationship?” 23:29 Is there a best practice for furthering the patient/doctor relationship from afar? 24:24 The need for a variety of approaches to patient/doctor connections. 27:30 What innovation initiatives need to be successful. 28:07 “People have to understand the ‘why.’” 29:38 The classic tenets of change management. 30:02 A challenge Dr. Romm is proud of having solved. 31:56 Secret weapon: collaboration. You can learn more by connecting with Dr. Romm on Twitter at @sylvia_romm. Check out our newest #healthcarepodcast with @sylvia_romm of @SonderHealth and @AtlanticHealth as she discusses human-centered #healthcare. #podcast #digitalhealth #healthtech #healthinnovation “How do we look at populations?” @sylvia_romm of @SonderHealth and @AtlanticHealth discusses human-centered #healthcare. #podcast #digitalhealth #healthtech #healthinnovation #healthcarepodcast “It’s really about affecting the system in its entirety.” @sylvia_romm of @SonderHealth and @AtlanticHealth discusses human-centered #healthcare. #podcast #digitalhealth #healthtech #healthinnovation #healthcarepodcast What does human-centered #healthcare mean? @sylvia_romm of @SonderHealth and @AtlanticHealth discusses. #podcast #digitalhealth #healthtech #healthinnovation #healthcarepodcast “You’re only as effective as the rapport that you build with [this] person.” @sylvia_romm of @SonderHealth and @AtlanticHealth discusses human-centered #healthcare. #podcast #digitalhealth #healthtech #healthinnovation #healthcarepodcast “What do people really need … but also, what do they find valuable?” @sylvia_romm of @SonderHealth and @AtlanticHealth discusses human-centered #healthcare. #podcast #digitalhealth #healthtech #healthinnovation #healthcarepodcast How are data folded into human-centered #healthcare? @sylvia_romm of @SonderHealth and @AtlanticHealth discusses. #podcast #digitalhealth #healthtech #healthinnovation #healthcarepodcast “The endgame is to figure out … how to have a better experience.” @sylvia_romm of @SonderHealth and @AtlanticHealth discusses human-centered #healthcare. #podcast #digitalhealth #healthtech #healthinnovation #healthcarepodcast “We are going to have to earn and learn agility.” @sylvia_romm of @SonderHealth and @AtlanticHealth discusses human-centered #healthcare. #podcast #digitalhealth #healthtech #healthinnovation #healthcarepodcast “Is this about you, and how do we know … how people outside feel about creating a relationship?” @sylvia_romm of @SonderHealth and @AtlanticHealth discusses human-centered #healthcare. #podcast #digitalhealth #healthtech #healthinnovation #healthcarepodcast What do innovation initiatives need to be successful? @sylvia_romm of @SonderHealth and @AtlanticHealth discusses human-centered #healthcare. #podcast #digitalhealth #healthtech #healthinnovation #healthcarepodcast “People have to understand the ‘why.’” @sylvia_romm of @SonderHealth and @AtlanticHealth discusses human-centered #healthcare. #podcast #digitalhealth #healthtech #healthinnovation #healthcarepodcast What are the classic tenets of change management? @sylvia_romm of @SonderHealth and @AtlanticHealth discusses human-centered #healthcare. #podcast #digitalhealth #healthtech #healthinnovation #healthcarepodcast Why collaboration is the secret weapon to innovation in health care. @sylvia_romm of @SonderHealth and @AtlanticHealth discusses human-centered #healthcare. #podcast #digitalhealth #healthtech #healthinnovation #healthcarepodcast

Kelley Butler is a rising 4th-year student at the University of California, Irvine School of Medicine. Hailing from Los Angeles, Kelley has committed herself to serve marginalized communities. She is an active member of various causes dedicated to students and professionals of color, people suffering from substance abuse disorder and addiction, people experiencing houselessness, and others. On her medical campus, Kelley is known for her work in social justice, health advocacy, and initiatives targeted for minority students. Kelley most recently completed her Masters of Public Health in Health Policy at the Harvard TH Chan School of Public Health. There, she leads organizing efforts in juvenile justice reform and prison divestment, presented research on substance use and addiction treatment, completed a fellowship in Equity, Diversity, and Inclusion, increased civic engagement on campus through the Harvard Votes Campaign, and oversaw a workshop series on Imposter Syndrome. She is currently implementing her new knowledge and skills next in Portland, Oregon as an Opioid Response Program Associate for Greater Oregon Behavioral Health Inc. Kelley graduated from Howard University in 2015 with a passion for serving communities without access to health insurance, quality healthcare or education. As such, she's dedicated herself to educating and serving both local and international communities in need. She's traveled to Panama, Kenya, and Angola on medical missions thus far and looks forward to continuing to be of service to all mankind.

21 May 2020 The #COVID19 series continues.: Resa speaks with Ashish Jha MD MPH and Miriam Laufer MD MPH.  They discuss the Atlantic magazine article ‘How Could the CDC Make That Mistake?', Hydroxychloroquine, Vaccines, Summer Camps, and opening institutions of higher learning (see NYTimes Op Ed by Christina Paxson) Dr. Ashish K. Jha is the K.T. Li Professor of Global Health at the Harvard TH Chan School of Public Health and Director of the Harvard Global Health Institute (HGHI). He is a practicing General Internist and is also Professor of Medicine at Harvard Medical School. Dr. Jha received his MD from Harvard Medical School and trained in Internal Medicine at the University of California in San Francisco. He completed his General Medicine fellowship at Brigham & Women's Hospital and received his MPH from the Harvard TH Chan School of Public Health. Dr. Jha is a member of the Institute of Medicine at the National Academies of Sciences, Engineering, and Medicine. In September, Dr. Jha will begin work as the Dean of the Brown University School of Public Health. Dr. Miriam Laufer is Professor of Pediatrics, Medicine, Epidemiology and Public Health, and Faculty of the graduate program in Microbiology and Immunology at the University of Maryland School of Medicine. She received her medical degree at the University of Pennsylvania and completed her residency in pediatrics at Babies and Children's Hospital of New York (now New York Children's Hospital) of Columbia University. She completed fellowships in pediatric infectious diseases at Johns Hopkins University and in malaria research at the Center for Vaccine Development at the University of Maryland. She received her MPH from the Bloomberg School of Public Health at Johns Hopkins University.

Dr Vikram Patel, Professor, Department of Global Health and Population, Harvard TH Chan School of Public Health, says the stringent lockdown imposed to clamp down on the coronavirus outbreak in India has led to panic migration, defeating the very purpose of clampdown. He talks about empathy not insensitivity, media responsibility and not ignoring those with chronic diseases, elderly, those living with mental health issues and our other vulnerable population.Guest: Dr Vikram Patel, Professor, Department of Global Health and Population, Harvard TH Chan School of Public HealthHost: Vaishali SoodEditor: Puneet Bhatia

Saadia Sediqzadah, MD joins us to discuss her personal connection to her research and practice, the role of activism in medicine, decision science and how it affects clinical practice, stigma in mental health, and so much more!Dr. Saadia Sediqzadah is a PGY-5 Psychiatry resident at the University of Toronto, with a strong interest in psychotic illnesses. She recently graduated with a Science Master’s in Health Policy and Management at the Harvard TH Chan School of Public Health. She also completed an Equity, Diversity and Inclusion Fellowship at Harvard. She proudly identifies as a daughter of Afghan refugees and as a first-generation Canadian. When she isn’t in clinic, she can be found biking around the city, coffee shop hopping, or dancing to Lizzo.Find Dr. Saadia Sediqzadah’s NEJM Perspective Article, “Sister First, Doctor Second,” online and follow her on Twitter! For more information about psychosis and related resources, visit the CAMH Psychosis page.This episode of Accidental Intellectual is produced by Bronwyn Lamond, Rachael Lyon, Harrison McNaughtan, Stephanie Morris, Lee Propp, and Ariana Simone. Our theme music is by Alexandra Willet and our branding by Maxwell McNaughtan.To learn more about the Accidental Intellectual podcast and get full show notes and a transcript of this episode, visit our website at www.accidentalintellectual.com.

Ellie Murray and Lucy D'Agostino McGowan try to keep it casual in the first episode of the new Casual Inference podcast. Episode 1 features special guest Miguel Hernan from Harvard TH Chan School of Public Health. Listen to learn how to improve your observational data analysis! Follow along on Twitter: The American Journal of Epidemiology: @AmJEpi Ellie: @EpiEllie Lucy: @LucyStats Miguel: @_MiguelHernan Our intro/outro music is courtesy of Joseph McDade. Here are some links to the content we talk about in this episode!  Causal Inference, What If: https://www.hsph.harvard.edu/miguel-hernan/causal-inference-book/ AJE article on applying the target trial method: https://academic.oup.com/aje/article/188/8/1569/5486454 AJE tweetorial on that article: https://twitter.com/AmJEpi/status/1171866941906026496  News report on the Economics Nobel Prize: https://www.sciencemag.org/news/2019/10/economics-nobel-honors-trio-taking-experimental-approach-fighting-poverty

This week’s episode features a dynamic couple and amazing leaders in advocacy, Student Doctors Shane Hervey and Kelley Butler. Both California natives, Shane is a 3rd year medical student at Oregon Health and Sciences University and Kelly is between her 3rd and 4th year at the University of California, Irvine School of Medicine. Kelley most recently completed her Masters of Public Health in Health Policy at the Harvard TH Chan School of Public Health where she lead organizing efforts in juvenile justice reform and prison divestment, presented research on substance use and addiction treatment, completed a fellowship in Equity, Diversity and Inclusion, increased civic engagement on campus through the Harvard Votes Campaign and oversaw a workshop series on Imposter Syndrome. Shane has dedicated himself to supporting underrepresented minority students pursuing careers in medicine as recipient of the President’s Scholarship and fervent advocate within the OHSU Center for Diversity and Inclusion. On campus, he has served in numerous capacities for the Student National Medical Association, has contributed to advocacy and action around gun violence and is currently participating in research surrounding adolescent suicide. We talked about their passion for social justice, how they maintain their relationship while in medical school, their dog Rosa Barks and what they'd do if they had a pet Elephant. Connect with MIC: Email: MedicineInColor@gmail.com Instagram: @MedicineInColor Twitter: @MedicineInColor

This week, hosts Mark Masselli and Margaret Flinter speak with former Missouri Governor Jay Nixon, now Senior Fellow at the Harvard TH Chan School of Public Health, on ways to create effective health policy in this hyper-partisan era. He discusses successful strategies he deployed as a Democratic governor in a red state that might prove effective across the country and in Washington.  The post The Art of Compromise: Missouri Governor Jay Nixon on Navigating Health Policy in Hyper-partisan Times appeared first on Healthy Communities Online.

U.S. Sen. Lamar Alexander (R-Tenn.), chair of the Senate Health Committee, appears to be ready to shepherd his 165-page draft legislation on surprise balance billing for a vote next week. In their push to get legislation prohibiting such billing through before the August recess, both the House and Senate have held hearings in the past two weeks on the various approaches to the problem. Those hearings have made the industry battle lines clearer, in terms of how the various industry sectors think that out-of-network providers should be compensated by payors. Although no single approach appears to be significantly favored at this point, Matthew Albright, former Centers for Medicare & Medicaid Services (CMS) official reports the lead story during this edition of Monitor Mondays. Other segments to appear during the live broadcast include:RAC Report: Healthcare attorney Knicole Emanuel returns to the broadcast to report on the latest audits by Recovery Audit Contractors (RACs) and other third-party auditors. Emanuel, a member of the RACmonitor editorial board, is a partner in the Potomac Law Group.SDoH Report: Ellen Fink-Samnick, a nationally recognized expert on social determinants of health (SdoH), has the latest news on this trending topic that is attracting significant media attention.CMS/IRF Settlement: As reported by RACmonitor, the Centers for Medicare & Medicaid Services (CMS) agreed last week to settle appeals for inpatient rehabilitation facilities (IRFs) following a two-year dispute with the industry. Reporting on this developing story will be Angela Phillips, president of Images & Associates, and one of the nation’s foremost IRF authorities.Links from Ellen's segment: Commonwealth Fund, Kaiser Family Foundation 1, Kaiser Family Foundation 2, Harvard TH Chan School of Public Health, Medicaid Work Requirements ChartNews from OMHA: The Office of Medicare Hearings and Appeals (OMHA) has expanded its Settlement Conference Facilitation (SCF) program, and it is now open to the appellant community. Healthcare attorney Andrew Wachler, a managing partner at Wachler and Associates, reports on how these expanded eligibility requirements provide new opportunities for appellants. Risky Business: Healthcare attorney David Glaser returns to Monitor Mondays with his popular segment, in which he reports on problematic issues facing providers.Links from David's segment: Supreme Court Case that says CMS must follow a more stringent process for issuing new rules than the Administrative Procedure Act requires.Fraud Alert: Genetic Testing ScamMonday Rounds: Ronald Hirsch, MD, vice president of R1 RCM, will be making his Monday Rounds with another installment of his popular segment.

This week hosts Mark Masselli and Margaret Flinter speak with Dr. Alain Chaoui, Past President of the Massachusetts Medical Society on their joint study, conducted with the Harvard TH Chan School of Public Health, on the ‘national health crisis’ of physician burnout in America. The post Mass Medical Society’s Dr. Alain Chaoui on Joint Harvard Study on the Crisis of Physician Burnout appeared first on Healthy Communities Online.

In this episode, You Okay, Sis?: Medical Apartheid, Ekemini and Christina are seated at the table with Harriet A. Washington. Harriet A. Washington wrote Infectious Madness: The Surprising Science of How We "Catch" Mental Illness while the 2015-2016 Miriam Shearing Fellow at the University of Nevada's Black Mountain Institute. She is a science writer, editor and ethicist who has been a Research Fellow in Medical Ethics at Harvard Medical School, Visiting Fellow at the Harvard TH Chan School of Public Health, a visiting scholar at DePaul University College of Law and a senior research scholar at the National Center for Bioethics at Tuskegee University. She has also held fellowships at Stanford University, holds a degree in English from the University of Rochester, an MA in journalism from Columbia University and in 2016 was elected a Fellow of the New York Academy of Medicine. She is a lecturer in bioethics at Columbia University. Ms. Washington has written widely for popular and science publications and has also been published in refereed books and journals such as Nature, JAMA, The American Journal of Public Health, The New England Journal of Medicine, The Harvard Public Health Review and The Journal of Law, Medicine, and Ethics. She has been Editor of the Harvard Journal of Minority Public Health and a guest editor of the Journal of Law, Medicine and Ethics. Her book A Terrible Thing to Waste: Environmental Racism and the Assault on the American Mind will be published in July 2019 and her other books include Deadly Monopolies: The Shocking Corporate Takeover of Life Itself—and the Consequences for Your Health and Our Medical Future and Medical Apartheid: The Dark History of Experimentation from Colonial Times to the Present, which won a National Book Critics Circle Award, the PEN/Oakland Award, and the American Library Association Black Caucus Nonfiction Award. In February 2018 the statue of James Marion Sims was removed from New York’s Central Park in response to Medical Apartheid’s exposure of his exploitive surgeries on enslaved black women. A film buff and lover of baroque music, Ms. Washington has also worked as a poison center manager, a classical-music announcer for public radio, and she curates a medical film series. Pull up a chair and have a seat at the table as Harriet A. Washington discusses Medical Apartheid with the women of Truth’s Table. Purchase Medical Apartheid: The Dark History of Experimentation from Colonial Times to the Present at your local bookstore or online. Warby Parker Free Home Try-On Code: warbyparker.com/table

Today's cryptocurrency and blockchain news. Bitcoin is down 1.3% $3,531 XRP is down 2.3% at 30 cents Ethereum is down 2.3% at $112 News out of DAVOS shows that New America, ConsenSys, and the Harvard TH Chan School of Public Health are collaborating with Levi Strauss & Co. on a two year pilot program to develop a blockchain-backed worker well-being system. Polymath is locking up approximately $9 million dollars worth of its tokens for the next 5 years. LibertyX becomes the first licensee to offer bitcoin purchasing options via ATMs to New York State residents. Mitsubish UFJ Financial Group has teamed up with the American company Akamai to build a blockchain based consumer payment network in time for the Tokyo Olmpyics.

If you've ever struggled with knowing what you want to get done, but have no idea how to do so, then do we have the well designed life, show for you!  Today I'll be talking with Dr. Kyra Bobinet, CEO of the design firm engagedIn, the recipient of the Harvard TH Chan School of Public Health Innovator award, and the author of a BRILLIANT new book on creating lasting change, The Well Designed Life. And that's just what I want to talk with her about today, about the truth about motivation and 10 lessons in Brain Science and Design Thinking for a Mindful, Healthy, and Purposeful Life, and how to GET DONE what you really want to do get done! Well Designed Life Self-Improvement & Self-Help Topics Include: What was the experience that shifted Dr. Bobinet's life from medicine to design work??? What's it mean to design our own lives? What is iterative change and why is iteration so important? What are the top 10 lessons in brain science and design thinking for a mindful, healthy, and purposeful life? What's it mean to design the change you want to see in the world? What can we learn from Dr. Fogg about our refrigerator? How can we work with our children's laziness (or our own)? What's the habenula in the brain? What can we learn from elephants in captivity about our brains? What's the importance of letting go of success, and instead welcoming in tinkering? What's the neuroscience behind compassion and empathy? What can we learn from Daniel Kahneman's Fast Brain, Slow Brain? What's the gap between what we want to do, and being able to do it – and how do we move past it? What are tiny habits? What's me, not me? What's the real truth about motivation? How do we design our lives for lasting change? What's it mean to track ourselves, and how can this help? What is deep tracking? What do we need to know about our future self and past self??? What's it mean to relapse and reboot? How do we free ourselves from attachment – and what's a Native American giveaway??? What do we need to know about helping our kids design there lives? What's an iterative mindset? To find out more visit: DrKyraBobinet.com and www.engagedIN.com Dr. Kyra Bobinet on the Neuroscience Behind Motivation & Getting Done What You Want to Get Done!!! Health | Law of Attraction | Motivation | Spiritual | Spirituality | Meditation | Inspirational | Motivational | Self-Improvement | Self-Help | Inspire For More Info Visit: www.InspireNationShow.com

If we could, most of us would want to live a long and vibrant life. But what’s the secret to longevity? A pill? A medical procedure? A recent study from the Harvard TH Chan School of Public Health shows us that 5 very simple healthy lifestyle factors is linked to a significantly longer and healthier life. In this episode, we breakdown the study into layman’s terms and share practical tips on how we can achieve these lifestyle factors in our own lives.LinksImpact of Healthy Lifestyle Factors on Life Expectancies in the US Population (Circulation)Harvard TH Chan School of Public HealthFive lifestyle habits that could add 10 or more years to life (CTV News)5 healthy habits to live by (Harvard Gazette)

Date: May 3, 2017 Featuring: John E. McDonough, DrPH, MPA, Professor of Practice, Harvard TH Chan School of Public Health John B. Chessare, MD, MPH, President and CEO, GBMC Healthcare (Baltimore, Maryland) A lot of the quality and safety improvements that have taken place in recent years in the US — think reducing hospital-acquired infections, creating safety cultures, implementing team-based primary care — have occurred regardless of what was or wasn't happening in Washington, DC. While political debates raged on, somehow the health care quality improvement movem​​ent continued to move ahead. However, with the enactment of the Affordable Care Act in 2010, government became more of a force for change, expanding access to care and insurance, and steering health care toward better value and performance. To understand what continues to keep some health care leaders up at night, we turned to GBMC Healthcare President and CEO, John Chessare. A member of the IHI Leadership Alliance and a strong proponent of population health and pursuing the Triple Aim, Dr. Chessare says many systems like his are changing for the better in ways most of the public knows nothing about. Dr. Chessare was joined by John McDonough, a prominent and prolific health care policy expert with decades of experience shaping, engaging with, and explaining health care policy. With the health care policy landscape changing on a daily basis, the May 3 WIHI: The High Stakes of Health Care Policy is a great place to start to understand the journey from the Affordable Care Act to where we may be heading.     

The 2014 west African Ebola epidemic shone a harsh light on the health systems of Guinea, Liberia, and Sierra Leone. While decades of domestic and international investment had contributed to substantial progress on the Millennium Development Goals, national health systems remained weak and were unable to cope with the epidemic. Margaret Kruk associate professor of global health at the Harvard TH Chan School of Public Health, joins us to discuss what makes a health system resilient, and how Liberia in particular has learned lessons from Ebola. Read the full analysis: http://www.bmj.com/content/357/bmj.j2323

Alongside weight and shape, global beauty standards place significant emphasis on skin colour. In this episode, Nadia and Jade look at the juxtaposition between the practice of tanning and skin-lightening and the research related to why people go to great efforts to change the colour of their skin. The episode features clips from the critically acclaimed documentary on the globalisation of beauty - The Illusionists - used with permission from film director Elena Rossini. Plus, hear an exclusive preview of an extract from Harvard’s latest teaching case study on skin lightening – thanks to Professor Bryn Austin and her team at STRIPED in the Harvard TH Chan School of Public Health. To download or stream the Illusionists: theillusionists.org To find out more and to download STRIPED public health teaching cases: www.hsph.harvard.edu/striped/teaching-cases/ For a short summary article on skin colour ideals: bit.ly/2kPBJek https://www.ted.com/talks/angelica_dass_the_beauty_of_human_skin_in_every_color Episode developed & produced by Nadia Craddock

Jennifer Leaning is the François-Xavier Bagnoud Professor of the Practice of Health and Human Rights at the Harvard TH Chan School of Public Health. In this extract, Professor Leaning talks about the violence that erupted during the traumatic migration caused by Partition.

  Carolyn: Welcome to Circulation on the Run, your weekly podcast summary and backstage pass to the journal and its editors. I'm Dr. Carolyn Lam, associate editor from National Heart Center and Duke National University in Singapore. Joining me today will be Dr. Katherine Mills and Dr. Andrew Moran to discuss the very striking findings of a new study on global disparities of hypertension prevalence and control, but first, here's the summary of this week's original papers.     In a study by first author, Dr. [Lu 00:00:42], corresponding author, Dr. Denny, from the Harvard TH Chan School of Public Health in Boston, Massachusetts and colleagues, authors aimed to investigate how the risk of cardiovascular disease is distributed among whites and blacks in the United States and how interventions on cardiovascular risk factors would reduce these racial disparities. To achieve these aims, the authors used a nationally representative sample of more than 6,000 adults, age 50-69 years of age, in the United States and developed a risk prediction model that was calibrated separately for blacks and whites.     The main results were that were substantial disparities in the risk of fatal cardiovascular disease; 25% of black men and 12% of black women were at high risk of fatal cardiovascular disease compared to only 10% of white men and 3% of white women, respectively. A large proportion of these fatal cardiovascular events among blacks were concentrated among this small proportion of the population. Now, whereas, population wide and interventions focused on single risk factors did not reduce black/white disparities in fatal cardiovascular risk and intervention that focused on high-risk individuals and reduced multiple risk factors simultaneously could indeed reduce black/white disparities in fatal cardiovascular disease by a quarter in men and a third in women.     These results really emphasize that focusing preventative interventions on the high-risk individuals has a large potential to improve overall cardiovascular health and reduce racial disparities in the United States.     The next paper is from first author, Dr. Lee, corresponding author, Dr. Federer, from Ohio State University Wexner Medical Center in Columbus Ohio and colleagues who looked at the issue of adenosine-induced atrial fibrillation and aimed to elucidate the molecular and functional mechanisms that may underlie this problem. To achieve this aim they integrated panoramic optical mapping and regional immunoblotting to allow them to resolve the protein expression of the two main components of the adenosine signaling pathway, mainly the A1R and GIRK4. They found that these signaling pathways were 2-3 times higher in the human right atrium compared to the left atrium leading to a greater right atrial action potential duration shortening in response to adenosine.     Furthermore, they showed that sustained adenosine-induced atrial fibrillation is maintained by re-entrant drivers localized in the lateral right atrial regions with the highest A1R and GIRK4 expression. Finally, the authors demonstrated that selective GIRK channel blockade successfully terminated and prevented atrial fibrillation. Thus, suggesting that the arrhythmogenic effect of adenosine in human atria may be mediated by activating GIRK channels. The take-home message, therefore, is that specific blockade of the GIRK channels may offer a novel mechanism to prevent adenosine mediated atrial fibrillation in patients.     The next study is from Dr. Nielsen and colleagues from the Copenhagen University Hospital of Bispebjerg in Copenhagen, Denmark, who aimed to assess the optimal blood pressure in patients with asymptomatic aortic valve stenosis. To achieve this aim, the authors used data from the simvastatin, ezetimibe in aortic stenosis or SEAS trial of 1,767 patients with asymptomatic aortic stenosis and no manifest atherosclerotic disease. Outcomes that were studied included all-cause mortality, cardiovascular death, heart failure, stroke, myocardial infarction, and aortic valve replacement. The main findings were that an average diastolic blood pressure above 90 and a systolic blood pressure above 160 millimeters mercury were associated with a poor outcome.     Furthermore, low systolic blood pressure was also related to adverse outcomes while low average diastolic blood pressure was harmful in moderate aortic stenosis. In summary, the optimal blood pressure, which was associated with the lowest risk of adverse outcomes, were the systolic blood pressure between 130 and 139 and a diastolic blood pressure between 70 and 90 millimeters mercury. The clinical take-home message is that in the scarcity of randomized controlled evidence, these results may assist clinicians in their decisions in blood pressure measurements in patients with aortic stenosis, meaning that a blood pressure above 149D may be treated while a blood pressure lower than 120 systolic or 60 diastolic may be recognized as a warning signal for poor outcomes.     That was the summary of this week's original papers. Now for a discussion of our feature paper.     I am so excited to be joined by two guests today to discuss our feature paper entitled Global Disparities of Hypertension Prevalence and Control, a systematic analysis of population-based studies from 90 countries. We are so pleased to have the first author, Dr. Katherine Mills, from Tulane University School of Public Health and Tropical Medicine in New Orleans. Welcome, Katherine.   Katherine: Thank you. Good morning.   Carolyn: And a very special occasion indeed, we have an editorialist joining us, as well, in none other than Dr. Andrew Moran from Columbia University Medical Center in New York. Welcome, Andrew.   Andrew: Good morning. Thank you, Carolyn.   Carolyn: It's wonderful to have you discuss this. This paper has so many key findings that really struck me. If you don't mind, I am just going to summarize some of these. For example, Katherine, you reported globally more than 30% of the adult population, amounting to almost 1.4 billion people have hypertension in 2010, and the prevalence of hypertension was higher in low and middle income countries than in the high income countries, making it, therefore, that approximately 75% of people living with hypertension live in the low and the middle income countries. Yet, hypertension awareness, treatment, and control were much lower in the low and middle income countries compared to the high income countries. That is really striking. Katherine, I'd really love for you to share with us what was the inspiration to look at this and what do you think was the most striking finding?   Katherine: We know that hypertension is a very important risk factor for cardiovascular and kidney disease. It's the leading cause of cardiovascular disease in the world and for premature death. A previous study in our research group found that about 26% of the world's adult population had hypertension in 2000, but since then there really hasn't been any global estimate made. Basically, since 2000, a lot of studies from individual countries and high income countries have shown a leveling off or decrease of hypertension prevalence, but studies from individual low and middle income countries have actually shown an increase in hypertension prevalence.     Given these trends in individual countries and the importance of hypertension prevalence and treatment and control, to prevent cardiovascular disease, we really wanted to look and see what the disparities were in high income compared to low and middle income countries. I think the most striking findings to me was that we found that over 75% of adults with hypertension globally are in low and middle income countries, and that's over a billion people. We also found that only 7.7% of those people with hypertension and low and middle income countries have controlled hypertension. That represents a huge global public health problem that could lead down the road to a large burden of cardiovascular and kidney disease if it's not effectively addressed.   Carolyn: Katherine, I could not agree with you more because it's actually a living reality that I'm seeing where I come from in Asia. We have just so much hypertension, and what struck me was that from 2000 to 2010, while the prevalence increased here, it decreased in high income countries. Yet, this is where the greatest need is and where the control is the lowest. That was striking. Can you just articulate a bit further how your data now add to the knowledge that was there before your paper?   Katherine: Basically, this is the first paper to show that the prevalence of hypertension is higher in low an middle income countries compared to high income countries. It's the first paper since 2000 to quantify the global burden of hypertension, and it's the first paper to really compare rates of awareness, treatment, and control comparing high income to low and middle income countries.   Carolyn: That is fantastic and really striking. I think that's why the Circulation Editorial Board to invite an editorial by Andrew to discuss this. Andrew, your editorial was entitled Still on the Road to Worldwide Hypertension Control, and even in the first sentence of your editorial, you mention that hypertension is a preventable risk factor, and that's why this is so important. I really like that your first subheading has this big word, action. Maybe you could tell us a bit more. What are the implications of these findings for worldwide hypertension control and actions that we can take?   Andrew: There's a growing attention to noncommunicable diseases worldwide as a lot of maternal and fetal deaths, those rates have improved worldwide, and so really as the world population ages, problems like hypertension and related noncommunicable diseases are becoming a bigger and bigger health problem for people around the world, not just in high income countries. As a matter of fact, recently the World Health Organization set a 25 by 25 goal, meaning to reduce deaths from noncommunicable diseases by 25% by the year 2025. A big part of that effort is going to be an effort to control hypertension. The World Heart Federation has set a goal of improving hypertension control by 25% as part of that overall effort.   Carolyn: Yes. You mentioned that I think in the editorial, as well, but are there some action steps that we could take globally as a community?   Andrew: Yes. It's striking to me as a practicing physician that something so basic as measuring blood pressure and recommending treatment for people with elevated blood pressure, which is so integral to our daily practice in medicine, that we still have so far to go in achieving control both in high income settings and low and middle income country settings. One of the most basic cornerstones of achieving control is proper measurement of blood pressure. I think one of the goal efforts has to involve making sure that primary care settings and even community centers have available well-calibrated and validated blood pressure measurement devices and that people know how to measure blood pressure accurately.     The other problems that come up with controlling hypertension are for people who have a diagnosis that is accurately made, are they able to follow up with a primary care provider to monitor their blood pressure, and do they have medications available to them that are affordable? It's important to note that especially in low and middle income countries, most people have to pay for their medications out of their own pockets, so the affordability and availability of medications is a really important part of achieving our goals. I think it's important to see that low and middle income countries, even though it can seem like a daunting setting in which to implement improvements in the quality of healthcare delivery, there also important places to experiment with improving the quality of care delivery worldwide.     For example, the concept of having a community health worker make home visits and reach out into the community was something that was developed in low and middle income countries and now is becoming a popular and effective method of delivering care in all countries worldwide.   Katherine: One thing I would add is that I think we really need collaborations from the international level because so many of these low and middle income countries have very limited healthcare resources, and there still dealing with a lot of infectious diseases, so I think it really is going to take an international effort to address this problem in low and middle income countries.   Carolyn: Thank you so much for joining us for another episode of Circulation on the Run. Tune in next week for more summaries and highlights.    

This month, AMA Journal of Ethics theme editor Abraar Karan, MD, and MPH candidate at the Harvard TH Chan School of Public Health, interviewed Agnes Bingowaho, MD, PhD, about practical challenges Rwanda overcame and ethical questions it faced while motivating better health outcomes for its people. Dr. Binagwaho is the minister of health of Rwanda.